No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 5acrA, 1.0000, 0.00, 1.000, 216, 216, W228Y-INVESTIGATION OF THE IMPACT FROM RESIDUES W228 AND Y233 IN THE METALLO-BETA-LACTAMASE GIM-1
2, 5acpA, 0.9969, 0.31, 0.995, 218, 216, W228R-INVESTIGATION OF THE IMPACT FROM RESIDUES W228 AND Y233 IN THE METALLO-BETA-LACTAMASE GIM-1
3, 5acqA, 0.9955, 0.37, 0.995, 217, 216, W228A-INVESTIGATION OF THE IMPACT FROM RESIDUES W228 AND Y233 IN THE METALLO-BETA-LACTAMASE GIM-1
4, 2ynvA, 0.9952, 0.39, 0.995, 216, 216, CYS221 OXIDIZED MONO ZINC GIM-1 - GIM-1-OX. CRYSTAL STRUCTURES OF PSEUDOMONAS AERUGINOSA GIM-1: ACTIVE SITE PLASTICITY IN METALLO-BETA-LACTAMASES
5, 5actA, 0.9944, 0.41, 0.995, 218, 216, W228S-INVESTIGATION OF THE IMPACT FROM RESIDUES W228 AND Y233 IN THE METALLO-BETA-LACTAMASE GIM-1
6, 5acsA, 0.9941, 0.44, 0.991, 218, 216, Y233A-INVESTIGATION OF THE IMPACT FROM RESIDUES W228 AND Y233 IN THE METALLO-BETA-LACTAMASE GIM-1
7, 2ynwA, 0.9931, 0.47, 0.995, 217, 216, GIM-1-2MOL NATIVE. CRYSTAL STRUCTURES OF PSEUDOMONAS AERUGINOSA GIM-1: ACTIVE SITE PLASTICITY IN METALLO-BETA-LACTAMASES
8, 5acsB, 0.9925, 0.50, 0.991, 217, 216, Y233A-INVESTIGATION OF THE IMPACT FROM RESIDUES W228 AND Y233 IN THE METALLO-BETA-LACTAMASE GIM-1
9, 2ynwB, 0.9924, 0.49, 0.995, 219, 216, GIM-1-2MOL NATIVE. CRYSTAL STRUCTURES OF PSEUDOMONAS AERUGINOSA GIM-1: ACTIVE SITE PLASTICITY IN METALLO-BETA-LACTAMASES
10, 5acpB, 0.9921, 0.49, 0.995, 216, 216, W228R-INVESTIGATION OF THE IMPACT FROM RESIDUES W228 AND Y233 IN THE METALLO-BETA-LACTAMASE GIM-1
11, 2ynuA, 0.9919, 0.50, 0.995, 217, 216, APO GIM-1 WITH 2MOL. CRYSTAL STRUCTURES OF PSEUDOMONAS AERUGINOSA GIM-1: ACTIVE SITE PLASTICITY IN METALLO-BETA-LACTAMASES
12, 2yntB, 0.9915, 0.52, 0.991, 219, 216, GIM-1-3MOL NATIVE. CRYSTAL STRUCTURES OF PSEUDOMONAS AERUGINOSA GIM-1: ACTIVE SITE PLASTICITY IN METALLO-BETA-LACTAMASES
13, 2yntC, 0.9905, 0.55, 0.995, 221, 216, GIM-1-3MOL NATIVE. CRYSTAL STRUCTURES OF PSEUDOMONAS AERUGINOSA GIM-1: ACTIVE SITE PLASTICITY IN METALLO-BETA-LACTAMASES
14, 5acqB, 0.9886, 0.60, 0.995, 216, 216, W228A-INVESTIGATION OF THE IMPACT FROM RESIDUES W228 AND Y233 IN THE METALLO-BETA-LACTAMASE GIM-1
15, 2ynvB, 0.9882, 0.62, 0.995, 217, 216, CYS221 OXIDIZED MONO ZINC GIM-1 - GIM-1-OX. CRYSTAL STRUCTURES OF PSEUDOMONAS AERUGINOSA GIM-1: ACTIVE SITE PLASTICITY IN METALLO-BETA-LACTAMASES
16, 5actB, 0.9857, 0.69, 0.995, 217, 216, W228S-INVESTIGATION OF THE IMPACT FROM RESIDUES W228 AND Y233 IN THE METALLO-BETA-LACTAMASE GIM-1
17, 2yntA, 0.9842, 0.78, 0.995, 221, 216, GIM-1-3MOL NATIVE. CRYSTAL STRUCTURES OF PSEUDOMONAS AERUGINOSA GIM-1: ACTIVE SITE PLASTICITY IN METALLO-BETA-LACTAMASES
18, 5acrB, 0.9813, 0.77, 1.000, 216, 216, W228Y-INVESTIGATION OF THE IMPACT FROM RESIDUES W228 AND Y233 IN THE METALLO-BETA-LACTAMASE GIM-1
19, 5mmdE, 0.9645, 1.30, 0.556, 221, 216, TMB-1. STRUCTURAL INSIGHTS INTO TMB-1 AND THE ROLE OF RESIDUE 119 AND 228 IN SUBSTRATE AND INHIBITOR BINDING
20, 5mmdF, 0.9638, 1.29, 0.556, 218, 216, TMB-1. STRUCTURAL INSIGHTS INTO TMB-1 AND THE ROLE OF RESIDUE 119 AND 228 IN SUBSTRATE AND INHIBITOR BINDING
21, 4zejA, 0.9612, 1.29, 0.521, 219, 215, CRYSTAL STRUCTURE OF DIM-1 METALLO-BETA-LACTAMASE EXPOSED TO CEFTAZIDIME
22, 4wd6A, 0.9608, 1.26, 0.521, 219, 215, CRYSTAL STRUCTURE OF DIM-1 METALLO-BETA-LACTAMASE
23, 4zejB, 0.9607, 1.32, 0.521, 219, 215, CRYSTAL STRUCTURE OF DIM-1 METALLO-BETA-LACTAMASE EXPOSED TO CEFTAZIDIME
24, 2ynuB, 0.9512, 0.48, 0.995, 208, 207, APO GIM-1 WITH 2MOL. CRYSTAL STRUCTURES OF PSEUDOMONAS AERUGINOSA GIM-1: ACTIVE SITE PLASTICITY IN METALLO-BETA-LACTAMASES
25, 4wd6B, 0.9504, 1.01, 0.521, 214, 211, CRYSTAL STRUCTURE OF DIM-1 METALLO-BETA-LACTAMASE
26, 5hh4C, 0.9467, 1.26, 0.479, 222, 213, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-1 IN COMPLEX WITH A PHOSPHONATE-BASED INHIBITOR
27, 4f6hA, 0.9462, 1.21, 0.474, 223, 213, MUTAGENESIS OF ZINC LIGAND RESIDUE CYS221 REVEALS PLASTICITY IN THE IMP-1 METALLO-B-LACTAMASE ACTIVE SITE
28, 5ev8C, 0.9461, 1.30, 0.479, 223, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE IMP-1 IN COMPLEX WITH THE BISTHIAZOLIDINE INHIBITOR D-CS319
29, 5ev6C, 0.9459, 1.28, 0.479, 222, 213, CRYSTAL STRUCTURE OF THE NATIVE DI-ZINC METALLO-BETA-LACTAMASE IMP-1
30, 4ubqA, 0.9459, 1.23, 0.460, 218, 213, CRYSTAL STRUCTURE OF IMP-2 METALLO-BETA-LACTAMASE FROM ACINETOBACTER SPP.
31, 4f6zA, 0.9458, 1.22, 0.479, 221, 213, MUTAGENESIS OF ZINC LIGAND RESIDUE CYS221 REVEALS PLASTICITY IN THE IMP-1 METALLO-B-LACTAMASE ACTIVE SITE
32, 5ev8D, 0.9457, 1.29, 0.479, 218, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE IMP-1 IN COMPLEX WITH THE BISTHIAZOLIDINE INHIBITOR D-CS319
33, 5ev8B, 0.9449, 1.35, 0.479, 219, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE IMP-1 IN COMPLEX WITH THE BISTHIAZOLIDINE INHIBITOR D-CS319
34, 5ewaC, 0.9445, 1.33, 0.479, 222, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE IMP-1 IN COMPLEX WITH THE BISTHIAZOLIDINE INHIBITOR L-VC26
35, 1jjtA, 0.9438, 1.43, 0.474, 220, 213, IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH A BIARYL SUCCINIC ACID INHIBITOR (1)
36, 1jjeB, 0.9436, 1.45, 0.479, 221, 213, IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH A BIARYL SUCCINIC ACID INHIBITOR (11)
37, 4uamC, 0.9433, 1.32, 0.479, 220, 213, 1.8 ANGSTROM CRYSTAL STRUCTURE OF IMP-1 METALLO-BETA-LACTAMASE WITH A MIXED IRON-ZINC CENTER IN THE ACTIVE SITE
38, 2dooA, 0.9432, 1.36, 0.479, 216, 213, THE STRUCTURE OF IMP-1 COMPLEXED WITH THE DETECTING REAGENT (DANSYLC4SH) BY A FLUORESCENT PROBE
39, 5ewaD, 0.9430, 1.36, 0.474, 219, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE IMP-1 IN COMPLEX WITH THE BISTHIAZOLIDINE INHIBITOR L-VC26
40, 1dd6B, 0.9429, 1.33, 0.474, 217, 213, IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH A MERCAPTOCARBOXYLATE INHIBITOR
41, 5hh4A, 0.9428, 1.47, 0.479, 218, 213, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-1 IN COMPLEX WITH A PHOSPHONATE-BASED INHIBITOR
42, 5ev8A, 0.9428, 1.42, 0.479, 219, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE IMP-1 IN COMPLEX WITH THE BISTHIAZOLIDINE INHIBITOR D-CS319
43, 5hh4B, 0.9424, 1.45, 0.479, 222, 213, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-1 IN COMPLEX WITH A PHOSPHONATE-BASED INHIBITOR
44, 5ewaB, 0.9423, 1.40, 0.479, 219, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE IMP-1 IN COMPLEX WITH THE BISTHIAZOLIDINE INHIBITOR L-VC26
45, 4uamB, 0.9423, 1.34, 0.479, 220, 213, 1.8 ANGSTROM CRYSTAL STRUCTURE OF IMP-1 METALLO-BETA-LACTAMASE WITH A MIXED IRON-ZINC CENTER IN THE ACTIVE SITE
46, 5y5bA, 0.9422, 1.36, 0.474, 221, 213, CRYSTAL STRUCTURE OF IMP-1 METALLO-BETA-LACTAMASE 
47, 5ewaA, 0.9422, 1.43, 0.474, 219, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE IMP-1 IN COMPLEX WITH THE BISTHIAZOLIDINE INHIBITOR L-VC26
48, 4uamA, 0.9422, 1.34, 0.479, 220, 213, 1.8 ANGSTROM CRYSTAL STRUCTURE OF IMP-1 METALLO-BETA-LACTAMASE WITH A MIXED IRON-ZINC CENTER IN THE ACTIVE SITE
49, 5ev6A, 0.9421, 1.50, 0.479, 219, 213, CRYSTAL STRUCTURE OF THE NATIVE DI-ZINC METALLO-BETA-LACTAMASE IMP-1
50, 2bmiB, 0.9419, 1.44, 0.335, 230, 215, METALLO-BETA-LACTAMASE
51, 1jjeA, 0.9416, 1.49, 0.474, 220, 213, IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH A BIARYL SUCCINIC ACID INHIBITOR (11)
52, 4uamD, 0.9415, 1.37, 0.479, 220, 213, 1.8 ANGSTROM CRYSTAL STRUCTURE OF IMP-1 METALLO-BETA-LACTAMASE WITH A MIXED IRON-ZINC CENTER IN THE ACTIVE SITE
53, 1wuoA, 0.9415, 1.39, 0.474, 218, 213, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-1 MUTANT (D81A)
54, 1wuoB, 0.9414, 1.37, 0.474, 218, 213, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-1 MUTANT (D81A)
55, 5b3rB, 0.9413, 1.46, 0.465, 219, 213, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-18 FROM PSEUDOMONAS AERUGINOSA
56, 4c1fB, 0.9413, 1.38, 0.474, 217, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE IMP-1 WITH L-CAPTOPRIL
57, 5ev6B, 0.9412, 1.49, 0.479, 223, 213, CRYSTAL STRUCTURE OF THE NATIVE DI-ZINC METALLO-BETA-LACTAMASE IMP-1
58, 4c1gB, 0.9411, 1.38, 0.474, 217, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE IMP-1 WITH D-CAPTOPRIL
59, 1a7tB, 0.9409, 1.52, 0.344, 227, 215, METALLO-BETA-LACTAMASE WITH MES
60, 2dooB, 0.9408, 1.39, 0.479, 216, 213, THE STRUCTURE OF IMP-1 COMPLEXED WITH THE DETECTING REAGENT (DANSYLC4SH) BY A FLUORESCENT PROBE
61, 1wuoC, 0.9408, 1.38, 0.469, 218, 213, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-1 MUTANT (D81A)
62, 1jjtB, 0.9404, 1.53, 0.474, 220, 213, IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH A BIARYL SUCCINIC ACID INHIBITOR (1)
63, 1dd6A, 0.9404, 1.44, 0.474, 216, 213, IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH A MERCAPTOCARBOXYLATE INHIBITOR
64, 1ddkA, 0.9403, 1.45, 0.474, 220, 213, CRYSTAL STRUCTURE OF IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA
65, 1a7tA, 0.9399, 1.52, 0.344, 227, 215, METALLO-BETA-LACTAMASE WITH MES
66, 5ev6D, 0.9393, 1.53, 0.474, 218, 213, CRYSTAL STRUCTURE OF THE NATIVE DI-ZINC METALLO-BETA-LACTAMASE IMP-1
67, 1wuoD, 0.9393, 1.42, 0.474, 218, 213, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-1 MUTANT (D81A)
68, 3wxcA, 0.9390, 1.49, 0.474, 217, 213, CRYSTAL STRUCTURE OF IMP-1 METALLO-BETA-LACTAMASE COMPLEXED WITH A 3- AMINOPHTALIC ACID INHIBITOR
69, 4c1fA, 0.9388, 1.51, 0.474, 219, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE IMP-1 WITH L-CAPTOPRIL
70, 5hh4D, 0.9387, 1.50, 0.474, 217, 213, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-1 IN COMPLEX WITH A PHOSPHONATE-BASED INHIBITOR
71, 3wxcB, 0.9387, 1.50, 0.474, 216, 213, CRYSTAL STRUCTURE OF IMP-1 METALLO-BETA-LACTAMASE COMPLEXED WITH A 3- AMINOPHTALIC ACID INHIBITOR
72, 4c1gA, 0.9383, 1.52, 0.474, 219, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE IMP-1 WITH D-CAPTOPRIL
73, 1wupC, 0.9364, 1.50, 0.474, 217, 213, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-1 MUTANT (D81E)
74, 3sfpA, 0.9362, 1.59, 0.298, 231, 215, CRYSTAL STRUCTURE OF THE MONO-ZINC-BOUNDFORM OF NEW DELHI METALLO- BETA-LACTAMASE-1 FROM KLEBSIELLA PNEUMONIAE
75, 2bmiA, 0.9360, 1.59, 0.335, 228, 215, METALLO-BETA-LACTAMASE
76, 1vgnA, 0.9359, 1.61, 0.474, 217, 213, STRUCTURE-BASED DESIGN OF THE IRREVERSIBLE INHIBITORS TO METALLO--LACTAMASE (IMP-1)
77, 4exyB, 0.9358, 1.63, 0.296, 239, 216, CRYSTAL STRUCTURE OF NDM-1 BOUND TO ETHYLENE GLYCOL
78, 1vgnB, 0.9358, 1.58, 0.479, 218, 213, STRUCTURE-BASED DESIGN OF THE IRREVERSIBLE INHIBITORS TO METALLO--LACTAMASE (IMP-1)
79, 1wupA, 0.9354, 1.53, 0.474, 217, 213, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-1 MUTANT (D81E)
80, 1wupD, 0.9353, 1.54, 0.474, 217, 213, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-1 MUTANT (D81E)
81, 3sfpB, 0.9347, 1.61, 0.298, 231, 215, CRYSTAL STRUCTURE OF THE MONO-ZINC-BOUNDFORM OF NEW DELHI METALLO- BETA-LACTAMASE-1 FROM KLEBSIELLA PNEUMONIAE
82, 5n0iB, 0.9346, 1.65, 0.296, 240, 216, CRYSTAL STRUCTURE OF NDM-1 IN COMPLEX WITH BETA-MERCAPTOETHANOL - NEW REFINEMENT
83, 1hlkB, 0.9345, 1.70, 0.344, 227, 215, METALLO-BETA-LACTAMASE FROM BACTEROIDES FRAGILIS IN COMPLEX WITH A TRICYCLIC INHIBITOR
84, 5b3rA, 0.9343, 1.28, 0.462, 214, 210, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-18 FROM PSEUDOMONAS AERUGINOSA
85, 1znbB, 0.9339, 1.43, 0.338, 230, 213, METALLO-BETA-LACTAMASE
86, 4exsA, 0.9338, 1.65, 0.296, 239, 216, CRYSTAL STRUCTURE OF NDM-1 BOUND TO L-CAPTOPRIL
87, 5n55A, 0.9337, 1.52, 0.343, 229, 213, MONO-ZINC VIM-5 METALLO-BETA-LACTAMASE IN COMPLEX WITH (1-CHLORO-4- HYDROXYISOQUINOLINE-3-CARBONYL)-L-TRYPTOPHAN (COMPOUND 2)
88, 5a5zC, 0.9337, 1.68, 0.296, 236, 216, APPROVED DRUGS CONTAINING THIOLS AS INHIBITORS OF METALLO- BETA-LACTAMASES: STRATEGY TO COMBAT MULTIDRUG-RESISTANT BACTERIA
89, 3spuD, 0.9337, 1.60, 0.298, 228, 215, APO NDM-1 CRYSTAL STRUCTURE
90, 1kr3B, 0.9337, 1.71, 0.344, 227, 215, CRYSTAL STRUCTURE OF THE METALLO BETA-LACTAMASE FROM BACTEROIDES FRAGILIS (CFIA) IN COMPLEX WITH THE TRICYCLIC INHIBITOR SB-236050.
91, 1wupB, 0.9333, 1.57, 0.474, 216, 213, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-1 MUTANT (D81E)
92, 4rl2B, 0.9332, 1.60, 0.298, 241, 215, STRUCTURAL AND MECHANISTIC INSIGHTS INTO NDM-1 CATALYZED HYDROLYSIS OF CEPHALOSPORINS
93, 1hlkA, 0.9330, 1.70, 0.335, 227, 215, METALLO-BETA-LACTAMASE FROM BACTEROIDES FRAGILIS IN COMPLEX WITH A TRICYCLIC INHIBITOR
94, 5ypkD, 0.9329, 1.61, 0.298, 229, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED IMIPENEM REPRESENTING AN EI2 COMPLEX
95, 4c1dA, 0.9327, 1.41, 0.347, 231, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-2 WITH L-CAPTOPRIL
96, 5ypkC, 0.9324, 1.61, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED IMIPENEM REPRESENTING AN EI2 COMPLEX
97, 1a8tB, 0.9324, 1.71, 0.344, 228, 215, METALLO-BETA-LACTAMASE IN COMPLEX WITH L-159061
98, 5lm6B, 0.9323, 1.42, 0.347, 231, 213, VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH 2-(3-FLUORO-4- HYDROXYPHENYL)-3-OXOISOINDOLINE-4-CARBOXYLIC ACID (COMPOUND 35)
99, 3znbB, 0.9323, 1.48, 0.333, 227, 213, METALLO-BETA-LACTAMASE (ZN HG-BOUND FORM)
100, 3znbA, 0.9322, 1.48, 0.333, 226, 213, METALLO-BETA-LACTAMASE (ZN HG-BOUND FORM)
101, 4nq2A, 0.9321, 1.43, 0.347, 230, 213, STRUCTURE OF ZN(II)-BOUND METALLO-BETA-LACTAMSE VIM-2 FROM PSEUDOMONAS AERUGINOSA
102, 5ypmE, 0.9320, 1.63, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED MEROPENEM REPRESENTING AN EI1 COMPLEX
103, 5ypkG, 0.9320, 1.61, 0.298, 229, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED IMIPENEM REPRESENTING AN EI2 COMPLEX
104, 4pvoA, 0.9320, 1.42, 0.347, 231, 213, CRYSTAL STRUCTURE OF VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH ML302 AND ML302F
105, 3q6xA, 0.9319, 1.60, 0.298, 241, 215, CRYSTAL STRUCTURE OF NDM-1 IN COMPLEX WITH HYDROLYZED AMPICILLIN
106, 5mxqA, 0.9318, 1.42, 0.347, 231, 213, CRYSTAL STRUCTURE OF THE ACQUIRED VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH ANT-90 INHIBITOR
107, 5ypnA, 0.9317, 1.62, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED MEROPENEM REPRESENTING AN EI2 COMPLEX
108, 5ypiC, 0.9317, 1.63, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED IMIPENEM REPRESENTING AN EI1 COMPLEX
109, 5ypkA, 0.9316, 1.62, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED IMIPENEM REPRESENTING AN EI2 COMPLEX
110, 5ypiG, 0.9316, 1.64, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED IMIPENEM REPRESENTING AN EI1 COMPLEX
111, 4eybA, 0.9316, 1.60, 0.298, 241, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED OXACILLIN
112, 5ypiD, 0.9315, 1.63, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED IMIPENEM REPRESENTING AN EI1 COMPLEX
113, 5mxrA, 0.9315, 1.44, 0.347, 232, 213, CRYSTAL STRUCTURE OF THE ACQUIRED VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH ANT-330 INHIBITOR
114, 1kr3A, 0.9315, 1.72, 0.335, 227, 215, CRYSTAL STRUCTURE OF THE METALLO BETA-LACTAMASE FROM BACTEROIDES FRAGILIS (CFIA) IN COMPLEX WITH THE TRICYCLIC INHIBITOR SB-236050.
115, 1ko3A, 0.9315, 1.44, 0.347, 230, 213, VIM-2 A ZN-BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA WITH CYS221 REDUCED
116, 5ypkF, 0.9314, 1.64, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED IMIPENEM REPRESENTING AN EI2 COMPLEX
117, 5ypiA, 0.9314, 1.63, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED IMIPENEM REPRESENTING AN EI1 COMPLEX
118, 5yplB, 0.9313, 1.64, 0.298, 229, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED IMIPENEM REPRESENTING AN EP COMPLEX
119, 1znbA, 0.9313, 1.49, 0.333, 228, 213, METALLO-BETA-LACTAMASE
120, 5ypiE, 0.9312, 1.64, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED IMIPENEM REPRESENTING AN EI1 COMPLEX
121, 5acwA, 0.9312, 1.43, 0.347, 232, 213, VIM-2-1 DISCOVERY OF NOVEL INHIBITOR SCAFFOLDS AGAINST THE METALLO-BETA-LACTAMASE VIM-2 BY SPR BASED FRAGMENT SCREENING
122, 4eyfA, 0.9312, 1.61, 0.298, 241, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED BENZYLPENICILLIN
123, 3pg4A, 0.9312, 1.58, 0.298, 230, 215, THE CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA LACTAMASE (NDM-1)
124, 5ypiF, 0.9311, 1.63, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED IMIPENEM REPRESENTING AN EI1 COMPLEX
125, 4tz9A, 0.9311, 1.65, 0.298, 231, 215, STRUCTURE OF METALLO-BETA-LACTAMASE
126, 2znbB, 0.9311, 1.39, 0.330, 226, 212, METALLO-BETA-LACTAMASE (CADMIUM-BOUND FORM)
127, 5n5iA, 0.9310, 1.54, 0.343, 232, 213, CRYSTAL STRUCTURE OF VIM-1 METALLO-BETA-LACTAMASE IN COMPLEX WITH HYDROLYSED MEROPENEM
128, 5ypmC, 0.9309, 1.65, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED MEROPENEM REPRESENTING AN EI1 COMPLEX
129, 4hl2A, 0.9309, 1.62, 0.298, 243, 215, NEW DELHI METALLO-BETA-LACTAMASE-1 1.05 A STRUCTURE COMPLEXED WITH HYDROLYZED AMPICILLIN
130, 5ypmA, 0.9307, 1.66, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED MEROPENEM REPRESENTING AN EI1 COMPLEX
131, 5ypmB, 0.9306, 1.65, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED MEROPENEM REPRESENTING AN EI1 COMPLEX
132, 5ypkB, 0.9306, 1.66, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED IMIPENEM REPRESENTING AN EI2 COMPLEX
133, 4c1eB, 0.9306, 1.44, 0.343, 231, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-2 WITH D-CAPTOPRIL
134, 4bz3A, 0.9306, 1.44, 0.347, 231, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-2
135, 5ypmH, 0.9305, 1.64, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED MEROPENEM REPRESENTING AN EI1 COMPLEX
136, 5ypmD, 0.9305, 1.64, 0.298, 229, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED MEROPENEM REPRESENTING AN EI1 COMPLEX
137, 4rl0B, 0.9305, 1.64, 0.298, 239, 215, STRUCTURAL AND MECHANISTIC INSIGHTS INTO NDM-1 CATALYZED HYDROLYSIS OF CEPHALOSPORINS
138, 3zr9A, 0.9305, 1.66, 0.298, 231, 215, STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE 1 (NDM-1)
139, 4uwsB, 0.9304, 1.54, 0.343, 229, 213, VIM-26-PEG. LEU224 IN VIM-26 FROM KLEBSIELLA PNEUMONIAE HAS IMPLICATIONS FOR DRUG BINDING.
140, 5o7nA, 0.9303, 1.44, 0.347, 231, 213, BETA-LACTAMASE VIM-2 IN COMPLEX WITH (2R)-1-(2-BENZYL-3- MERCAPTOPROPANOYL)PIPERIDINE-2-CARBOXYLIC ACID 
141, 5lscB, 0.9303, 1.45, 0.347, 235, 213, THE STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-2 IN COMPLEX WITH A TRIAZOLYLTHIOACETAMIDE INHIBITOR
142, 4pvtA, 0.9303, 1.45, 0.347, 231, 213, CRYSTAL STRUCTURE OF VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH ML302F
143, 4h0dA, 0.9303, 1.63, 0.298, 241, 215, NEW DELHI METALLO-BETA-LACTAMASE-1 COMPLEXED WITH MN FROM KLEBSIELLA PNEUMONIAE
144, 5n4tB, 0.9302, 1.48, 0.347, 232, 213, VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH ((S)-3-MERCAPTO-2- METHYLPROPANOYL)-L-TRYPTOPHAN (COMPOUND 4)
145, 4eyfB, 0.9302, 1.63, 0.298, 241, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED BENZYLPENICILLIN
146, 5k48A, 0.9301, 1.47, 0.347, 231, 213, VIM-2 METALLO BETA LACTAMASE IN COMPLEX WITH 3-(MERCAPTOMETHYL)-[11 - BIPHENYL]-4-CARBOXYLIC ACID
147, 4tzbA, 0.9301, 1.66, 0.298, 231, 215, STRUCTURE OF NDM-METALLO-BETA-LACTAMASE
148, 4rawA, 0.9301, 1.63, 0.298, 241, 215, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 MUTANT M67V COMPLEXED WITH HYDROLYZED AMPICILLIN
149, 5yplA, 0.9300, 1.65, 0.298, 229, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED IMIPENEM REPRESENTING AN EP COMPLEX
150, 5n55B, 0.9300, 1.57, 0.343, 230, 213, MONO-ZINC VIM-5 METALLO-BETA-LACTAMASE IN COMPLEX WITH (1-CHLORO-4- HYDROXYISOQUINOLINE-3-CARBONYL)-L-TRYPTOPHAN (COMPOUND 2)
151, 4znbA, 0.9299, 1.51, 0.324, 227, 213, METALLO-BETA-LACTAMASE (C181S MUTANT)
152, 4ey2A, 0.9299, 1.63, 0.298, 241, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED METHICILLIN
153, 3q6xB, 0.9299, 1.64, 0.298, 241, 215, CRYSTAL STRUCTURE OF NDM-1 IN COMPLEX WITH HYDROLYZED AMPICILLIN
154, 5ypnB, 0.9298, 1.66, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED MEROPENEM REPRESENTING AN EI2 COMPLEX
155, 5ypkH, 0.9297, 1.66, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED IMIPENEM REPRESENTING AN EI2 COMPLEX
156, 5a5zA, 0.9297, 1.76, 0.296, 236, 216, APPROVED DRUGS CONTAINING THIOLS AS INHIBITORS OF METALLO- BETA-LACTAMASES: STRATEGY TO COMBAT MULTIDRUG-RESISTANT BACTERIA
157, 4rbsA, 0.9297, 1.68, 0.298, 231, 215, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 IN THE COMPLEX WITH HYDROLYZED MEROPENEM
158, 4fsbB, 0.9297, 1.46, 0.343, 231, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-31 IN ITS OXIDIZED FORM AT 1.88 A
159, 3spuA, 0.9297, 1.66, 0.298, 228, 215, APO NDM-1 CRYSTAL STRUCTURE
160, 4tzeB, 0.9296, 1.64, 0.298, 229, 215, STRUCTURE OF METALLO-BETA-LACTAMASE
161, 4hl2B, 0.9296, 1.65, 0.298, 242, 215, NEW DELHI METALLO-BETA-LACTAMASE-1 1.05 A STRUCTURE COMPLEXED WITH HYDROLYZED AMPICILLIN
162, 3srxA, 0.9296, 1.68, 0.298, 237, 215, NEW DELHI METALLO-BETA-LACTAMASE-1 COMPLEXED WITH CD
163, 3sfpC, 0.9296, 1.69, 0.298, 231, 215, CRYSTAL STRUCTURE OF THE MONO-ZINC-BOUNDFORM OF NEW DELHI METALLO- BETA-LACTAMASE-1 FROM KLEBSIELLA PNEUMONIAE
164, 5ypiB, 0.9295, 1.67, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED IMIPENEM REPRESENTING AN EI1 COMPLEX
165, 4eybB, 0.9294, 1.64, 0.298, 241, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED OXACILLIN
166, 4hkyB, 0.9293, 1.63, 0.298, 241, 215, NEW DELHI METALLO-BETA-LACTAMASE-1 COMPLEXED WITH CD AND FAROPENEM
167, 3srxB, 0.9293, 1.67, 0.298, 229, 215, NEW DELHI METALLO-BETA-LACTAMASE-1 COMPLEXED WITH CD
168, 5n4sA, 0.9292, 1.50, 0.347, 231, 213, VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH ((S)-3-MERCAPTO-2- METHYLPROPANOYL)-D-TRYPTOPHAN (COMPOUND 3)
169, 4tzfA, 0.9292, 1.67, 0.298, 229, 215, STRUCTURE OF METALLO-BETA LACTAMASE
170, 4uwrB, 0.9291, 1.55, 0.343, 229, 213, MONO-ZINC VIM-26. LEU224 IN VIM-26 FROM KLEBSIELLA PNEUMONIAE HAS IMPLICATIONS FOR DRUG BINDING.
171, 4rl2A, 0.9291, 1.64, 0.298, 241, 215, STRUCTURAL AND MECHANISTIC INSIGHTS INTO NDM-1 CATALYZED HYDROLYSIS OF CEPHALOSPORINS
172, 4exsB, 0.9291, 1.78, 0.296, 231, 216, CRYSTAL STRUCTURE OF NDM-1 BOUND TO L-CAPTOPRIL
173, 5a87B, 0.9290, 1.57, 0.343, 234, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-5
174, 5mm9B, 0.9289, 1.48, 0.347, 231, 213, VIM-2_2B. METALLO-BETA-LACTAMASE INHIBITORS BY BIOISOSTERIC REPLACEMENT: PREPARATION ACTIVITY AND BINDING
175, 4uwoB, 0.9289, 1.58, 0.343, 229, 213, NATIVE DI-ZINC VIM-26. LEU224 IN VIM-26 FROM KLEBSIELLA PNEUMONIAE HAS IMPLICATIONS FOR DRUG BINDING.
176, 4rawB, 0.9289, 1.65, 0.298, 241, 215, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 MUTANT M67V COMPLEXED WITH HYDROLYZED AMPICILLIN
177, 4eylA, 0.9289, 1.79, 0.296, 231, 216, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED MEROPENEM
178, 3sfpD, 0.9289, 1.69, 0.298, 232, 215, CRYSTAL STRUCTURE OF THE MONO-ZINC-BOUNDFORM OF NEW DELHI METALLO- BETA-LACTAMASE-1 FROM KLEBSIELLA PNEUMONIAE
179, 5n0hA, 0.9288, 1.79, 0.296, 233, 216, CRYSTAL STRUCTURE OF NDM-1 IN COMPLEX WITH HYDROLYZED MEROPENEM - NEW REFINEMENT
180, 4ua4B, 0.9288, 1.53, 0.347, 234, 213, STRUCTURE OF THE VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH A BISTHIAZOLIDINE INHIBITOR
181, 4c1dB, 0.9288, 1.49, 0.347, 231, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-2 WITH L-CAPTOPRIL
182, 3spuC, 0.9288, 1.69, 0.298, 228, 215, APO NDM-1 CRYSTAL STRUCTURE
183, 5fqcA, 0.9286, 1.50, 0.347, 231, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-2 WITH 2C
184, 4uwpB, 0.9286, 1.59, 0.343, 229, 213, PENTA ZN1 COORDINATION. LEU224 IN VIM-26 FROM KLEBSIELLA PNEUMONIAE HAS IMPLICATIONS FOR DRUG BINDING.
185, 6ex7B, 0.9284, 1.65, 0.298, 241, 215, CRYSTAL STRUCTURE OF NDM-1 METALLO-BETA-LACTAMASE IN COMPLEX WITH CD IONS AND A HYDROLYZED BETA-LACTAM LIGAND - NEW REFINEMENT
186, 5o7nB, 0.9284, 1.50, 0.347, 232, 213, BETA-LACTAMASE VIM-2 IN COMPLEX WITH (2R)-1-(2-BENZYL-3- MERCAPTOPROPANOYL)PIPERIDINE-2-CARBOXYLIC ACID 
187, 5acvA, 0.9284, 1.47, 0.343, 232, 213, VIM-2-OX DISCOVERY OF NOVEL INHIBITOR SCAFFOLDS AGAINST THE METALLO-BETA-LACTAMASE VIM-2 BY SPR BASED FRAGMENT SCREENING
188, 4znbB, 0.9284, 1.36, 0.332, 223, 211, METALLO-BETA-LACTAMASE (C181S MUTANT)
189, 4ey2B, 0.9284, 1.66, 0.298, 241, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED METHICILLIN
190, 5y6dB, 0.9283, 1.54, 0.347, 231, 213, VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH (R)-2-(4-FLUOROPHENYL)-2- ((S)-3-MERCAPTO-2-METHYLPROPANAMIDO)ACETIC ACID (COMPOUND 11)
191, 4h0dB, 0.9283, 1.67, 0.298, 241, 215, NEW DELHI METALLO-BETA-LACTAMASE-1 COMPLEXED WITH MN FROM KLEBSIELLA PNEUMONIAE
192, 1ko2A, 0.9283, 1.48, 0.347, 229, 213, VIM-2 A ZN-BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA WITH AN OXIDIZED CYS (CYSTEINESULFONIC)
193, 5lscA, 0.9282, 1.49, 0.347, 235, 213, THE STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-2 IN COMPLEX WITH A TRIAZOLYLTHIOACETAMIDE INHIBITOR
194, 1a8tA, 0.9282, 1.85, 0.335, 230, 215, METALLO-BETA-LACTAMASE IN COMPLEX WITH L-159061
195, 4ramA, 0.9281, 1.60, 0.299, 239, 214, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 MUTANT M67V COMPLEXED WITH HYDROLYZED PENICILLIN G
196, 4hl1B, 0.9281, 1.68, 0.298, 240, 215, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 COMPLEXED WITH CD AND AMPICILLIN
197, 5ypmF, 0.9279, 1.70, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED MEROPENEM REPRESENTING AN EI1 COMPLEX
198, 5k48B, 0.9279, 1.53, 0.347, 232, 213, VIM-2 METALLO BETA LACTAMASE IN COMPLEX WITH 3-(MERCAPTOMETHYL)-[11 - BIPHENYL]-4-CARBOXYLIC ACID
199, 4d1tA, 0.9279, 1.33, 0.370, 229, 211, HIGH RESOLUTION STRUCTURE OF NATIVE TVIM-7 FROM PSEUDOMONAS AERUGINOSA
200, 5acvB, 0.9277, 1.51, 0.343, 232, 213, VIM-2-OX DISCOVERY OF NOVEL INHIBITOR SCAFFOLDS AGAINST THE METALLO-BETA-LACTAMASE VIM-2 BY SPR BASED FRAGMENT SCREENING
201, 5wihA, 0.9276, 1.69, 0.293, 229, 215, STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE 12 (NDM-12)
202, 5acwB, 0.9276, 1.52, 0.347, 232, 213, VIM-2-1 DISCOVERY OF NOVEL INHIBITOR SCAFFOLDS AGAINST THE METALLO-BETA-LACTAMASE VIM-2 BY SPR BASED FRAGMENT SCREENING
203, 4fsbA, 0.9276, 1.53, 0.347, 231, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-31 IN ITS OXIDIZED FORM AT 1.88 A
204, 5n0iA, 0.9275, 1.81, 0.296, 232, 216, CRYSTAL STRUCTURE OF NDM-1 IN COMPLEX WITH BETA-MERCAPTOETHANOL - NEW REFINEMENT
205, 5lm6A, 0.9275, 1.53, 0.347, 231, 213, VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH 2-(3-FLUORO-4- HYDROXYPHENYL)-3-OXOISOINDOLINE-4-CARBOXYLIC ACID (COMPOUND 35)
206, 6ex7A, 0.9274, 1.66, 0.298, 240, 215, CRYSTAL STRUCTURE OF NDM-1 METALLO-BETA-LACTAMASE IN COMPLEX WITH CD IONS AND A HYDROLYZED BETA-LACTAM LIGAND - NEW REFINEMENT
207, 5a87A, 0.9274, 1.58, 0.343, 230, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-5
208, 4exyA, 0.9274, 1.81, 0.296, 231, 216, CRYSTAL STRUCTURE OF NDM-1 BOUND TO ETHYLENE GLYCOL
209, 4rbsB, 0.9273, 1.60, 0.299, 241, 214, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 IN THE COMPLEX WITH HYDROLYZED MEROPENEM
210, 5acxB, 0.9272, 1.55, 0.347, 232, 213, VIM-2-2 DISCOVERY OF NOVEL INHIBITOR SCAFFOLDS AGAINST THE METALLO-BETA-LACTAMASE VIM-2 BY SPR BASED FRAGMENT SCREENING
211, 4pvoB, 0.9272, 1.54, 0.343, 233, 213, CRYSTAL STRUCTURE OF VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH ML302 AND ML302F
212, 5y6dC, 0.9271, 1.61, 0.347, 231, 213, VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH (R)-2-(4-FLUOROPHENYL)-2- ((S)-3-MERCAPTO-2-METHYLPROPANAMIDO)ACETIC ACID (COMPOUND 11)
213, 4eylB, 0.9270, 1.79, 0.296, 240, 216, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED MEROPENEM
214, 5ypkE, 0.9267, 1.70, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED IMIPENEM REPRESENTING AN EI2 COMPLEX
215, 5n0hB, 0.9265, 1.81, 0.296, 240, 216, CRYSTAL STRUCTURE OF NDM-1 IN COMPLEX WITH HYDROLYZED MEROPENEM - NEW REFINEMENT
216, 4hl1A, 0.9263, 1.65, 0.299, 238, 214, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 COMPLEXED WITH CD AND AMPICILLIN
217, 5ypiH, 0.9261, 1.71, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED IMIPENEM REPRESENTING AN EI1 COMPLEX
218, 5lchA, 0.9261, 1.63, 0.347, 230, 213, VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH (S)-1-ALLYL-2-(3- METHOXYPHENYL)-3-OXOISOINDOLINE-4-CARBOXYLIC ACID (COMPOUND 42)
219, 5acxA, 0.9261, 1.46, 0.349, 231, 212, VIM-2-2 DISCOVERY OF NOVEL INHIBITOR SCAFFOLDS AGAINST THE METALLO-BETA-LACTAMASE VIM-2 BY SPR BASED FRAGMENT SCREENING
220, 4tyfA, 0.9261, 1.71, 0.298, 230, 215, STRUCTURE OF A METALLO-BETA-LACTAMASE
221, 4pvtB, 0.9261, 1.57, 0.343, 231, 213, CRYSTAL STRUCTURE OF VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH ML302F
222, 2wrsA, 0.9259, 1.61, 0.343, 230, 213, CRYSTAL STRUCTURE OF THE MONO-ZINC METALLO-BETA-LACTAMASE VIM-4 FROM PSEUDOMONAS AERUGINOSA
223, 5ypmG, 0.9258, 1.72, 0.298, 228, 215, CRYSTAL STRUCTURE OF NDM-1 BOUND TO HYDROLYZED MEROPENEM REPRESENTING AN EI1 COMPLEX
224, 5naiA, 0.9256, 1.63, 0.343, 230, 213, MONO-ZINC VIM-5 METALLO-BETA-LACTAMASE IN COMPLEX WITH (1-CHLORO-4- HYDROXYISOQUINOLINE-3-CARBONYL)-D-TRYPTOPHAN (COMPOUND 1)
225, 5fqcB, 0.9256, 1.58, 0.347, 231, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-2 WITH 2C
226, 4tzeA, 0.9256, 1.72, 0.298, 230, 215, STRUCTURE OF METALLO-BETA-LACTAMASE
227, 4bz3B, 0.9256, 1.56, 0.343, 232, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-2
228, 5wigA, 0.9255, 1.73, 0.298, 229, 215, STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE 4 (NDM-4)
229, 5n5hA, 0.9255, 1.64, 0.343, 234, 213, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE VIM-1 IN COMPLEX WITH ML302F INHIBITOR
230, 4fr7A, 0.9255, 1.63, 0.352, 231, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-31 IN ITS REDUCED FORM AT 1.61 A
231, 5mm9A, 0.9253, 1.56, 0.347, 232, 213, VIM-2_2B. METALLO-BETA-LACTAMASE INHIBITORS BY BIOISOSTERIC REPLACEMENT: PREPARATION ACTIVITY AND BINDING
232, 4u4lB, 0.9253, 1.73, 0.298, 231, 215, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE NDM-1 IN COMPLEX WITH A BISTHIAZOLIDINE INHIBITOR
233, 5n55C, 0.9252, 1.57, 0.340, 227, 212, MONO-ZINC VIM-5 METALLO-BETA-LACTAMASE IN COMPLEX WITH (1-CHLORO-4- HYDROXYISOQUINOLINE-3-CARBONYL)-L-TRYPTOPHAN (COMPOUND 2)
234, 5n4tA, 0.9252, 1.60, 0.343, 234, 213, VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH ((S)-3-MERCAPTO-2- METHYLPROPANOYL)-L-TRYPTOPHAN (COMPOUND 4)
235, 2whgB, 0.9252, 1.64, 0.343, 230, 213, CRYSTAL STRUCTURE OF THE DI-ZINC METALLO-BETA-LACTAMASE VIM- 4 FROM PSEUDOMONAS AERUGINOSA
236, 5n4sB, 0.9251, 1.60, 0.343, 230, 213, VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH ((S)-3-MERCAPTO-2- METHYLPROPANOYL)-D-TRYPTOPHAN (COMPOUND 3)
237, 3spuE, 0.9250, 1.67, 0.299, 227, 214, APO NDM-1 CRYSTAL STRUCTURE
238, 4ramB, 0.9249, 1.65, 0.299, 239, 214, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 MUTANT M67V COMPLEXED WITH HYDROLYZED PENICILLIN G
239, 5y6eB, 0.9247, 1.59, 0.347, 231, 213, VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH (R)-2-(4-HYDROXYPHENYL)- 2-((S)-3-MERCAPTO-2-METHYLPROPANAMIDO)ACETIC ACID (COMPOUND 12)
240, 5y6eA, 0.9247, 1.59, 0.347, 231, 213, VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH (R)-2-(4-HYDROXYPHENYL)- 2-((S)-3-MERCAPTO-2-METHYLPROPANAMIDO)ACETIC ACID (COMPOUND 12)
241, 5wigB, 0.9247, 1.75, 0.298, 229, 215, STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE 4 (NDM-4)
242, 5ni0A, 0.9247, 1.63, 0.347, 230, 213, VIM-2_10C. METALLO-BETA-LACTAMASE INHIBITORS BY BIOISOSTERIC REPLACEMENT: PREPARATION ACTIVITY AND BINDING
243, 5nhzA, 0.9247, 1.63, 0.347, 230, 213, VIM-2_10B. METALLO-BETA-LACTAMASE INHIBITORS BY BIOISOSTERIC REPLACEMENT: PREPARATION ACTIVITY AND BINDING
244, 3spuB, 0.9244, 1.60, 0.300, 238, 213, APO NDM-1 CRYSTAL STRUCTURE
245, 2whgA, 0.9244, 1.66, 0.343, 230, 213, CRYSTAL STRUCTURE OF THE DI-ZINC METALLO-BETA-LACTAMASE VIM- 4 FROM PSEUDOMONAS AERUGINOSA
246, 5xp6A, 0.9243, 1.75, 0.298, 229, 215, NATIVE STRUCTURE OF NDM-1 CRYSTALLIZED AT PH5.5
247, 2wrsB, 0.9241, 1.63, 0.343, 230, 213, CRYSTAL STRUCTURE OF THE MONO-ZINC METALLO-BETA-LACTAMASE VIM-4 FROM PSEUDOMONAS AERUGINOSA
248, 5acuA, 0.9238, 1.52, 0.349, 230, 212, VIM-2-NAT DISCOVERY OF NOVEL INHIBITOR SCAFFOLDS AGAINST THE METALLO-BETA-LACTAMASE VIM-2 BY SPR BASED FRAGMENT SCREENING
249, 5xp9A, 0.9234, 1.76, 0.298, 228, 215, CRYSTAL STRUCTURE OF BISMUTH BOUND NDM-1
250, 4c1eA, 0.9233, 1.52, 0.349, 230, 212, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-2 WITH D-CAPTOPRIL
251, 5k4kK, 0.9231, 1.86, 0.288, 228, 215, DIRECTED EVOLUTIONARY CHANGES IN MBL SUPER FAMILY - NDM-1 ROUND 10 CRYSTAL-4
252, 5k4kA, 0.9229, 1.87, 0.288, 228, 215, DIRECTED EVOLUTIONARY CHANGES IN MBL SUPER FAMILY - NDM-1 ROUND 10 CRYSTAL-4
253, 5k4mA, 0.9228, 1.87, 0.288, 228, 215, DIRECTED EVOLUTIONARY CHANGES IN MBL SUPER FAMILY - NDM-1 ROUND 10 CRYSTAL-3
254, 5y6dA, 0.9226, 1.62, 0.347, 230, 213, VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH (R)-2-(4-FLUOROPHENYL)-2- ((S)-3-MERCAPTO-2-METHYLPROPANAMIDO)ACETIC ACID (COMPOUND 11)
255, 5k4nA, 0.9221, 1.87, 0.288, 228, 215, DIRECTED EVOLUTIONARY CHANGES IN MBL SUPER FAMILY - NDM-1 ROUND 10 CRYSTAL-2
256, 5y6dD, 0.9218, 1.62, 0.347, 230, 213, VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH (R)-2-(4-FLUOROPHENYL)-2- ((S)-3-MERCAPTO-2-METHYLPROPANAMIDO)ACETIC ACID (COMPOUND 11)
257, 5nhzB, 0.9211, 1.66, 0.347, 230, 213, VIM-2_10B. METALLO-BETA-LACTAMASE INHIBITORS BY BIOISOSTERIC REPLACEMENT: PREPARATION ACTIVITY AND BINDING
258, 2znbA, 0.9209, 1.34, 0.330, 222, 209, METALLO-BETA-LACTAMASE (CADMIUM-BOUND FORM)
259, 4d1wA, 0.9206, 1.37, 0.371, 226, 210, A H224Y MUTANT FOR VIM-7 FROM PSEUDOMONAS AERUGINOSA
260, 5jqjA, 0.9205, 1.90, 0.288, 228, 215, DIRECTED EVOLUTIONARY CHANGES IN MBL SUPER FAMILY - NDM-1 ROUND 10 CRYSTAL-1
261, 4gyqB, 0.9199, 1.98, 0.293, 232, 215, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 D223A MUTANT FROM KLEBSIELLA PNEUMONIAE
262, 4nq4A, 0.9198, 1.46, 0.371, 221, 210, BACILLUS CEREUS ZN-DEPENDENT METALLO-BETA-LACTAMASE AT PH 7
263, 4hkyA, 0.9196, 1.70, 0.291, 228, 213, NEW DELHI METALLO-BETA-LACTAMASE-1 COMPLEXED WITH CD AND FAROPENEM
264, 4c1hA, 0.9194, 1.48, 0.371, 221, 210, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE BCII WITH L-CAPTOPRIL
265, 4c09A, 0.9193, 1.48, 0.371, 223, 210, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE BCII
266, 2y8bA, 0.9192, 1.33, 0.373, 225, 209, VIM-7 WITH OXIDISED. STRUCTURAL AND COMPUTATIONAL INVESTIGATIONS OF VIM-7: INSIGHTS INTO THE SUBSTRATE SPECIFICITY OF VIM  METALLO-BETA-LACTAMASES
267, 3s0zA, 0.9191, 1.81, 0.296, 220, 213, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE (NDM-1)
268, 1bvtA, 0.9191, 1.49, 0.371, 221, 210, METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS 569/H/9
269, 5le1A, 0.9190, 1.64, 0.349, 229, 212, VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH 2-(2-CHLORO-6- FLUOROBENZYL)-3-OXOISOINDOLINE-4-CARBOXYLIC ACID (COMPOUND 16)
270, 4gyuA, 0.9188, 1.77, 0.299, 241, 214, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 A121F MUTANT FROM KLEBSIELLA PNEUMONIAE
271, 5ni0E, 0.9184, 1.65, 0.344, 229, 212, VIM-2_10C. METALLO-BETA-LACTAMASE INHIBITORS BY BIOISOSTERIC REPLACEMENT: PREPARATION ACTIVITY AND BINDING
272, 4rl0A, 0.9184, 1.71, 0.296, 230, 213, STRUCTURAL AND MECHANISTIC INSIGHTS INTO NDM-1 CATALYZED HYDROLYSIS OF CEPHALOSPORINS
273, 5lcaA, 0.9180, 1.68, 0.344, 222, 212, VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH 3-OXO-2-(3- (TRIFLUOROMETHYL)PHENYL)ISOINDOLINE-4-CARBOXYLIC ACID (COMPOUND 17)
274, 5n5gA, 0.9179, 1.64, 0.341, 233, 211, CRYSTAL STRUCTURE OF DI-ZINC METALLO-BETA-LACTAMASE VIM-1
275, 5lcfA, 0.9179, 1.71, 0.344, 222, 212, VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH 3-OXO-2- PHENYLISOINDOLINE-4-CARBOXYLIC ACID (COMPOUND 30)
276, 3rkkB, 0.9179, 1.82, 0.298, 226, 215, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 FROM KLEBSIELLA PNEUMONIAE
277, 3rkjB, 0.9178, 1.82, 0.298, 226, 215, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 FROM KLEBSIELLA PNUEUMONIAE
278, 2y87A, 0.9177, 1.46, 0.371, 227, 210, NATIVE VIM-7. STRUCTURAL AND COMPUTATIONAL INVESTIGATIONS OF VIM-7: INSIGHTS INTO THE SUBSTRATE SPECIFICITY OF VIM METALLO-BETA-LACTAMASES
279, 4d1vA, 0.9175, 1.47, 0.367, 227, 210, A F218Y MUTANT OF VIM-7 FROM PSEUDOMONAS AERUGINOSA
280, 4gyqC, 0.9174, 1.83, 0.294, 237, 214, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 D223A MUTANT FROM KLEBSIELLA PNEUMONIAE
281, 3s0zB, 0.9174, 1.67, 0.297, 220, 212, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE (NDM-1)
282, 1dxkA, 0.9173, 1.55, 0.367, 221, 210, METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS 569/H/9 C168S MUTANT
283, 4ua4A, 0.9171, 1.58, 0.346, 230, 211, STRUCTURE OF THE VIM-2 METALLO-BETA-LACTAMASE IN COMPLEX WITH A BISTHIAZOLIDINE INHIBITOR
284, 4u4lA, 0.9168, 1.66, 0.297, 229, 212, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE NDM-1 IN COMPLEX WITH A BISTHIAZOLIDINE INHIBITOR
285, 3sblA, 0.9160, 1.78, 0.299, 232, 214, CRYSTAL STRUCTURE OF NEW DELHI METAL-BETA-LACTAMASE-1 FROM KLEBSIELLA PNEUMONIAE
286, 4gyqD, 0.9154, 1.88, 0.294, 230, 214, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 D223A MUTANT FROM KLEBSIELLA PNEUMONIAE
287, 4nq6A, 0.9152, 1.59, 0.367, 222, 210, BACILLUS CEREUS ZN-DEPENDENT METALLO-BETA-LACTAMASE AT PH 7 COMPLEXED WITH COMPOUND L-CS319
288, 3rkjA, 0.9151, 1.92, 0.298, 226, 215, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 FROM KLEBSIELLA PNUEUMONIAE
289, 2y8aA, 0.9141, 1.45, 0.373, 226, 209, VIM-7 WITH OXIDISED. STRUCTURAL AND COMPUTATIONAL INVESTIGATIONS OF VIM-7: INSIGHTS INTO THE SUBSTRATE SPECIFICITY OF VIM METALLO-BETA-LACTAMASES
290, 5n58B, 0.9139, 1.60, 0.343, 219, 210, DI-ZINC VIM-5 METALLO-BETA-LACTAMASE IN COMPLEX WITH (1-CHLORO-4- HYDROXYISOQUINOLINE-3-CARBONYL)-D-TRYPTOPHAN (COMPOUND 1)
291, 3rkkA, 0.9139, 1.94, 0.298, 227, 215, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 FROM KLEBSIELLA PNEUMONIAE
292, 4gyqA, 0.9135, 1.68, 0.292, 236, 212, CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 D223A MUTANT FROM KLEBSIELLA PNEUMONIAE
293, 1m2xB, 0.9134, 1.70, 0.315, 219, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE BLAB OF CHRYSEOBACTERIUM MENINGOSEPTICUM IN COMPLEX WITH THE INHIBITOR D- CAPTOPRIL
294, 1m2xC, 0.9132, 1.70, 0.315, 217, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE BLAB OF CHRYSEOBACTERIUM MENINGOSEPTICUM IN COMPLEX WITH THE INHIBITOR D- CAPTOPRIL
295, 4d1uA, 0.9130, 1.48, 0.368, 226, 209, A D120A MUTANT OF VIM-7 FROM PSEUDOMONAS AERUGINOSA
296, 1m2xD, 0.9128, 1.70, 0.315, 219, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE BLAB OF CHRYSEOBACTERIUM MENINGOSEPTICUM IN COMPLEX WITH THE INHIBITOR D- CAPTOPRIL
297, 1m2xA, 0.9126, 1.70, 0.315, 219, 213, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE BLAB OF CHRYSEOBACTERIUM MENINGOSEPTICUM IN COMPLEX WITH THE INHIBITOR D- CAPTOPRIL
298, 2bfkA, 0.9121, 1.51, 0.364, 220, 209, BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH7 USING 20MM ZNSO4 IN BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT
299, 4rm5A, 0.9114, 1.66, 0.289, 226, 211, STRUCTURAL AND MECHANISTIC INSIGHTS INTO NDM-1 CATALYZED HYDROLYSIS OF CEPHALOSPORINS
300, 5n58A, 0.9112, 1.62, 0.343, 220, 210, DI-ZINC VIM-5 METALLO-BETA-LACTAMASE IN COMPLEX WITH (1-CHLORO-4- HYDROXYISOQUINOLINE-3-CARBONYL)-D-TRYPTOPHAN (COMPOUND 1)
301, 3knrA, 0.9108, 1.60, 0.371, 214, 210, BACILLUS CEREUS METALLO-BETA-LACTAMASE CYS221ASP MUTANT 1 MM ZN(II)
302, 3knsA, 0.9102, 1.61, 0.371, 214, 210, BACILLUS CEREUS METALLO-BETA-LACTAMASE CYS221ASP MUTANT 20 MM ZN(II)
303, 2bg8A, 0.9098, 1.47, 0.365, 218, 208, BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH4.5 USING 20 MICROMOLAR ZNSO4 IN THE BUFFER. 1MM DTT AND 1MM TCEP-HCL WERE USED AS REDUCING AGENTS.
304, 3fczA, 0.9095, 1.41, 0.362, 219, 207, ADAPTIVE PROTEIN EVOLUTION GRANTS ORGANISMAL FITNESS BY IMPROVING CATALYSIS AND FLEXIBILITY
305, 3fczB, 0.9094, 1.41, 0.362, 219, 207, ADAPTIVE PROTEIN EVOLUTION GRANTS ORGANISMAL FITNESS BY IMPROVING CATALYSIS AND FLEXIBILITY
306, 3knrC, 0.9089, 1.55, 0.373, 213, 209, BACILLUS CEREUS METALLO-BETA-LACTAMASE CYS221ASP MUTANT 1 MM ZN(II)
307, 2bfkB, 0.9085, 1.50, 0.365, 220, 208, BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH7 USING 20MM ZNSO4 IN BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT
308, 4u4lC, 0.9082, 1.66, 0.295, 223, 210, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE NDM-1 IN COMPLEX WITH A BISTHIAZOLIDINE INHIBITOR
309, 4nq7A, 0.9081, 1.46, 0.372, 218, 207, BACILLUS CEREUS ZN-DEPENDENT METALLO-BETA-LACTAMASE AT PH 7 COMPLEXED WITH COMPOUND D-VC26
310, 3knsC, 0.9080, 1.57, 0.373, 213, 209, BACILLUS CEREUS METALLO-BETA-LACTAMASE CYS221ASP MUTANT 20 MM ZN(II)
311, 2bflB, 0.9079, 1.52, 0.365, 220, 208, BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH5 USING 20MM ZNSO4 IN BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT.
312, 1mqoA, 0.9079, 1.78, 0.371, 221, 210, METALLO-BETA-LACTAMASE BCII CD SUBSTITUTED FROM BACILLUS CEREUS AT 1.35 ANGSTROMS RESOLUTION
313, 4rm5B, 0.9066, 1.61, 0.292, 222, 209, STRUCTURAL AND MECHANISTIC INSIGHTS INTO NDM-1 CATALYZED HYDROLYSIS OF CEPHALOSPORINS
314, 4c1cA, 0.9066, 1.40, 0.374, 218, 206, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE BCII WITH D-CAPTOPRIL
315, 5fqbA, 0.9064, 1.50, 0.372, 219, 207, CRYSTAL STRUCTURE OF BACILLUS CEREUS METALLO-BETA-LACTAMASE WITH 2C
316, 2bg2A, 0.9064, 1.46, 0.367, 218, 207, BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH4.5 USING 20MM ZNSO4 IN THE BUFFER. 1MM DTT AND 1MM TCEP-HCL WERE USED AS REDUCING AGENTS. CYS221 IS REDUCED.
317, 4rm5D, 0.9062, 1.61, 0.292, 223, 209, STRUCTURAL AND MECHANISTIC INSIGHTS INTO NDM-1 CATALYZED HYDROLYSIS OF CEPHALOSPORINS
318, 2uyxA, 0.9059, 1.41, 0.369, 218, 206, METALLO-BETA-LACTAMASE (1BC2) SINGLE POINT MUTANT D120S
319, 2bc2A, 0.9059, 1.47, 0.372, 217, 207, METALLO BETA-LACTAMASE II FROM BACILLUS CEREUS 569/H/9 AT PH 6.0 TRIGONAL CRYSTAL FORM
320, 2yz3A, 0.9050, 1.61, 0.351, 225, 208, CRYSTALLOGRAPHIC INVESTIGATION OF INHIBITION MODE OF THE VIM-2 METALLO-BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA WITH MERCAPTOCARBOXYLATE INHIBITOR
321, 4rm5C, 0.9049, 1.71, 0.290, 223, 210, STRUCTURAL AND MECHANISTIC INSIGHTS INTO NDM-1 CATALYZED HYDROLYSIS OF CEPHALOSPORINS
322, 2bg7B, 0.9048, 1.50, 0.367, 218, 207, BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH4.5 USING 20 MICROMOLAR ZNSO4 IN THE BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT. CYS221 IS OXIDIZED.
323, 4tytA, 0.9047, 1.44, 0.374, 218, 206, CRYSTAL STRUCTURE OF BCII METALLO-BETA-LACTAMASE IN COMPLEX WITH ML302F
324, 4u4lD, 0.9045, 1.66, 0.297, 224, 209, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE NDM-1 IN COMPLEX WITH A BISTHIAZOLIDINE INHIBITOR
325, 2bg8B, 0.9045, 1.49, 0.367, 219, 207, BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH4.5 USING 20 MICROMOLAR ZNSO4 IN THE BUFFER. 1MM DTT AND 1MM TCEP-HCL WERE USED AS REDUCING AGENTS.
326, 5w8wA, 0.9044, 1.44, 0.374, 218, 206, BACILLUS CEREUS ZN-DEPENDENT METALLO-BETA-LACTAMASE AT PH 7 - NEW REFINEMENT
327, 5fqaA, 0.9026, 1.40, 0.376, 216, 205, CRYSTAL STRUCTURE OF BACILLUS CEREUS METALLO-BETA-LACTAMASE II
328, 5jmxA, 0.9025, 1.39, 0.376, 217, 205, CRYSTAL STRUCTURE OF BCII METALLO-BETA-LACTAMASE IN COMPLEX WITH DZ- 305
329, 2bg7A, 0.9022, 1.46, 0.369, 216, 206, BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH4.5 USING 20 MICROMOLAR ZNSO4 IN THE BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT. CYS221 IS OXIDIZED.
330, 2yz3B, 0.9017, 1.66, 0.351, 225, 208, CRYSTALLOGRAPHIC INVESTIGATION OF INHIBITION MODE OF THE VIM-2 METALLO-BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA WITH MERCAPTOCARBOXYLATE INHIBITOR
331, 3bc2A, 0.9014, 1.40, 0.376, 214, 205, METALLO BETA-LACTAMASE II FROM BACILLUS CEREUS 569/H/9 AT PH 6.0 MONOCLINIC CRYSTAL FORM
332, 2bg6B, 0.9011, 1.49, 0.369, 217, 206, BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH5 USING 20 MICROMOLAR ZNSO4 IN THE BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT. CYS221 IS OXIDIZED.
333, 2bgaA, 0.9010, 1.50, 0.369, 216, 206, BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH7 USING 20 MICROMOLAR ZNSO4 IN THE BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT. CYS221 IS OXIDIZED.
334, 2bfzB, 0.9009, 1.49, 0.369, 217, 206, BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH4.5 USING 20MM ZNSO4 IN BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT. CYS221 IS OXIDIZED.
335, 2bgaB, 0.9005, 1.51, 0.369, 217, 206, BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH7 USING 20 MICROMOLAR ZNSO4 IN THE BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT. CYS221 IS OXIDIZED.
336, 2bg2B, 0.8999, 1.50, 0.369, 218, 206, BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH4.5 USING 20MM ZNSO4 IN THE BUFFER. 1MM DTT AND 1MM TCEP-HCL WERE USED AS REDUCING AGENTS. CYS221 IS REDUCED.
337, 2bfzA, 0.8996, 1.43, 0.371, 215, 205, BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH4.5 USING 20MM ZNSO4 IN BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT. CYS221 IS OXIDIZED.
338, 4nq5A, 0.8993, 1.37, 0.377, 215, 204, BACILLUS CEREUS ZN-DEPENDENT METALLO-BETA-LACTAMASE AT PH 7 COMPLEXED WITH COMPOUND CS319
339, 1bc2A, 0.8993, 1.44, 0.376, 216, 205, ZN-DEPENDENT METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS
340, 2bg6A, 0.8986, 1.44, 0.371, 215, 205, BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH5 USING 20 MICROMOLAR ZNSO4 IN THE BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT. CYS221 IS OXIDIZED.
341, 2bflA, 0.8985, 1.45, 0.371, 216, 205, BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH5 USING 20MM ZNSO4 IN BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT.
342, 3iogA, 0.8982, 1.51, 0.214, 227, 206, CRYSTAL STRUCTURE OF CPHA N220G MUTANT WITH INHIBITOR 18
343, 2nxaA, 0.8979, 1.39, 0.373, 215, 204, STRUCTURE OF ZN-DEPENDENT METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS R121H C221D DOUBLE MUTANT
344, 1bc2B, 0.8971, 1.48, 0.376, 216, 205, ZN-DEPENDENT METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS
345, 2nypA, 0.8968, 1.41, 0.373, 215, 204, STRUCTURE OF BETA-LACTAMASE II FROM BACILLUS CEREUS. R121H C221D DOBLE MUTANT WITH TWO ZINC IONS.
346, 3l6nA, 0.8967, 1.84, 0.261, 218, 211, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IND-7
347, 2nzeB, 0.8967, 1.48, 0.371, 217, 205, STRUCTURE OF BETA-LACTAMASE II FROM BACILLUS CEREUS. R121H C221S DOUBLE MUTANT. SPACE GROUP P3121.
348, 2bc2B, 0.8964, 1.49, 0.376, 215, 205, METALLO BETA-LACTAMASE II FROM BACILLUS CEREUS 569/H/9 AT PH 6.0 TRIGONAL CRYSTAL FORM
349, 3iofA, 0.8963, 1.54, 0.214, 227, 206, CRYSTAL STRUCTURE OF CPHA N220G MUTANT WITH INHIBITOR 10A
350, 3faiA, 0.8960, 1.54, 0.214, 227, 206, THE DI ZINC CARBAPENEMASE CPHA N220G MUTANT
351, 2nzfA, 0.8960, 1.42, 0.373, 215, 204, STRUCTURE OF BETA-LACTAMASE II FROM BACILLUS CEREUS. R121H C221S DOUBLE MUTANT. SPACE GROUP C2.
352, 1x8hA, 0.8960, 1.54, 0.214, 227, 206, THE MONO-ZINC CARBAPENEMASE CPHA (N220G MUTANT) SHOWS A ZN(II)- NH2 ARG COORDINATION
353, 3i13A, 0.8959, 1.36, 0.379, 214, 203, BACILLUS CEREUS ZN-DEPENDENT METALLO-BETA-LACTAMASE AT PH 5.8
354, 3i14A, 0.8951, 1.38, 0.379, 215, 203, COBALT-SUBSTITUTED METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS: RESIDUE CYS168 PARTIALLY OXIDIZED
355, 3i11A, 0.8951, 1.37, 0.379, 215, 203, COBALT-SUBSTITUTED METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS
356, 3f9oA, 0.8947, 1.53, 0.210, 226, 205, CRYSTAL STRUCTURE OF THE DI-ZINC CARBAPENEMASE CPHA FROM AEROMONAS HYDROPHILA
357, 3sd9A, 0.8939, 1.52, 0.224, 230, 205, CRYSTAL STRUCTURE OF SERRATIA FONTICOLA SFH-I: SOURCE OF THE NUCLEOPHILE IN THE CATALYTIC MECHANISM OF MONO-ZINC METALLO-BETA- LACTAMASES
358, 2nzeA, 0.8938, 1.44, 0.373, 215, 204, STRUCTURE OF BETA-LACTAMASE II FROM BACILLUS CEREUS. R121H C221S DOUBLE MUTANT. SPACE GROUP P3121.
359, 2fhxB, 0.8938, 1.50, 0.317, 244, 205, PSEUDOMONAS AERUGINOSA SPM-1 METALLO-BETA-LACTAMASE
360, 4bp0D, 0.8932, 1.52, 0.317, 244, 205, CRYSTAL STRUCTURE OF THE CLOSED FORM OF PSEUDOMONAS AERUGINOSA SPM-1
361, 2fhxA, 0.8932, 1.51, 0.317, 244, 205, PSEUDOMONAS AERUGINOSA SPM-1 METALLO-BETA-LACTAMASE
362, 2m5dA, 0.8930, 1.85, 0.371, 227, 210, SOLUTION STRUCTURE OF THE BACILLUS CEREUS METALLO-BETA-LACTAMASE BCII IN COMPLEX WITH R-THIOMANDELIC ACID
363, 1bmcA, 0.8924, 1.33, 0.376, 213, 202, STRUCTURE OF A ZINC METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS
364, 2gklA, 0.8921, 1.39, 0.212, 224, 203, CRYSTAL STRUCTURE OF THE ZINC CARBAPENEMASE CPHA IN COMPLEX WITH THE INHIBITOR PYRIDINE-24-DICARBOXYLATE
365, 3sd9B, 0.8917, 1.47, 0.225, 229, 204, CRYSTAL STRUCTURE OF SERRATIA FONTICOLA SFH-I: SOURCE OF THE NUCLEOPHILE IN THE CATALYTIC MECHANISM OF MONO-ZINC METALLO-BETA- LACTAMASES
366, 4bp0B, 0.8916, 1.55, 0.317, 245, 205, CRYSTAL STRUCTURE OF THE CLOSED FORM OF PSEUDOMONAS AERUGINOSA SPM-1
367, 1x8iA, 0.8915, 1.48, 0.216, 224, 204, CRYSTAL STRUCTURE OF THE ZINC CARBAPENEMASE CPHA IN COMPLEX WITH THE ANTIBIOTIC BIAPENEM
368, 5ndbB, 0.8914, 1.55, 0.317, 245, 205, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE SPM-1 COMPLEXED WITH CYCLOBUTANONE INHIBITOR
369, 4bp0A, 0.8913, 1.55, 0.317, 246, 205, CRYSTAL STRUCTURE OF THE CLOSED FORM OF PSEUDOMONAS AERUGINOSA SPM-1
370, 4bp0C, 0.8912, 1.55, 0.317, 244, 205, CRYSTAL STRUCTURE OF THE CLOSED FORM OF PSEUDOMONAS AERUGINOSA SPM-1
371, 2qdsA, 0.8908, 1.48, 0.211, 224, 204, CRYSTAL STRUCTURE OF THE ZINC CARBAPENEMASE CPHA IN COMPLEX WITH THE INHIBITOR D-CAPTOPRIL
372, 5ndeB, 0.8906, 1.56, 0.317, 247, 205, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE SPM-1 IN SPACE GROUP P4222
373, 1x8gA, 0.8904, 1.50, 0.211, 224, 204, CRYSTAL STRUCTURE OF THE MONO-ZINC CARBAPENEMASE CPHA FROM AEROMONAS HYDROPHYLA
374, 3i15A, 0.8903, 1.38, 0.376, 213, 202, COBALT-SUBSTITUTED METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS: RESIDUE CYS168 FULLY OXIDIZED
375, 5ndbA, 0.8902, 1.58, 0.317, 244, 205, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE SPM-1 COMPLEXED WITH CYCLOBUTANONE INHIBITOR
376, 3i0vA, 0.8890, 1.58, 0.384, 210, 203, BACILLUS CEREUS METALLO-BETA-LACTAMASE: APO FORM
377, 5ls3A, 0.8887, 1.59, 0.317, 239, 205, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE SPM-1 WITH Y58C MUTATION
378, 3q6vB, 0.8887, 1.44, 0.222, 228, 203, CRYSTAL STRUCTURE OF SERRATIA FONTICOLA SFH-I: GLYCEROL COMPLEX
379, 3q6vA, 0.8887, 1.43, 0.222, 228, 203, CRYSTAL STRUCTURE OF SERRATIA FONTICOLA SFH-I: GLYCEROL COMPLEX
380, 5ls3B, 0.8882, 1.60, 0.317, 245, 205, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE SPM-1 WITH Y58C MUTATION
381, 5ew0A, 0.8882, 1.44, 0.222, 228, 203, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE SFH-I IN COMPLEX WITH THE BISTHIAZOLIDINE INHIBITOR L-CS319
382, 5ndeA, 0.8867, 1.62, 0.317, 244, 205, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE SPM-1 IN SPACE GROUP P4222
383, 5ew0B, 0.8863, 1.47, 0.222, 228, 203, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE SFH-I IN COMPLEX WITH THE BISTHIAZOLIDINE INHIBITOR L-CS319
384, 2m5cA, 0.8846, 1.88, 0.371, 227, 210, SOLUTION STRUCTURE OF THE BACILLUS CEREUS METALLO-BETA-LACTAMASE BCII
385, 3knrB, 0.8832, 1.41, 0.378, 205, 201, BACILLUS CEREUS METALLO-BETA-LACTAMASE CYS221ASP MUTANT 1 MM ZN(II)
386, 3knrD, 0.8828, 1.42, 0.378, 205, 201, BACILLUS CEREUS METALLO-BETA-LACTAMASE CYS221ASP MUTANT 1 MM ZN(II)
387, 3knsD, 0.8823, 1.43, 0.378, 205, 201, BACILLUS CEREUS METALLO-BETA-LACTAMASE CYS221ASP MUTANT 20 MM ZN(II)
388, 3knsB, 0.8823, 1.43, 0.378, 205, 201, BACILLUS CEREUS METALLO-BETA-LACTAMASE CYS221ASP MUTANT 20 MM ZN(II)
389, 2ohhA, 0.8324, 2.83, 0.163, 403, 215, CRYSTAL STRUCTURE OF COENZYME F420H2 OXIDASE (FPRA) A DIIRON FLAVOPROTEIN ACTIVE OXIDIZED STATE
390, 2ohiG, 0.8297, 2.86, 0.167, 403, 215, CRYSTAL STRUCTURE OF COENZYME F420H2 OXIDASE (FPRA) A DIIRON FLAVOPROTEIN REDUCED STATE
391, 4dilB, 0.8275, 2.66, 0.171, 396, 210, FLAVO DI-IRON PROTEIN H90N MUTANT FROM THERMOTOGA MARITIMA
392, 2ohhD, 0.8269, 2.86, 0.167, 403, 215, CRYSTAL STRUCTURE OF COENZYME F420H2 OXIDASE (FPRA) A DIIRON FLAVOPROTEIN ACTIVE OXIDIZED STATE
393, 5v8sB, 0.8265, 2.68, 0.176, 396, 210, FLAVO DI-IRON PROTEIN H90D MUTANT FROM THERMOTOGA MARITIMA
394, 2ohiB, 0.8265, 2.90, 0.167, 403, 215, CRYSTAL STRUCTURE OF COENZYME F420H2 OXIDASE (FPRA) A DIIRON FLAVOPROTEIN REDUCED STATE
395, 5v8sA, 0.8263, 2.67, 0.176, 399, 210, FLAVO DI-IRON PROTEIN H90D MUTANT FROM THERMOTOGA MARITIMA
396, 4dilA, 0.8263, 2.68, 0.176, 392, 210, FLAVO DI-IRON PROTEIN H90N MUTANT FROM THERMOTOGA MARITIMA
397, 2ohhE, 0.8258, 2.85, 0.167, 403, 215, CRYSTAL STRUCTURE OF COENZYME F420H2 OXIDASE (FPRA) A DIIRON FLAVOPROTEIN ACTIVE OXIDIZED STATE
398, 2ohjE, 0.8251, 2.93, 0.167, 403, 215, CRYSTAL STRUCTURE OF COENZYME F420H2 OXIDASE (FPRA) A DIIRON FLAVOPROTEIN INACTIVE OXIDIZED STATE
399, 4dikB, 0.8248, 2.69, 0.171, 400, 210, FLAVO DI-IRON PROTEIN H90A MUTANT FROM THERMOTOGA MARITIMA
400, 4dikA, 0.8248, 2.69, 0.176, 402, 210, FLAVO DI-IRON PROTEIN H90A MUTANT FROM THERMOTOGA MARITIMA
401, 2ohjA, 0.8248, 2.93, 0.167, 403, 215, CRYSTAL STRUCTURE OF COENZYME F420H2 OXIDASE (FPRA) A DIIRON FLAVOPROTEIN INACTIVE OXIDIZED STATE
402, 2ohiJ, 0.8248, 2.93, 0.167, 403, 215, CRYSTAL STRUCTURE OF COENZYME F420H2 OXIDASE (FPRA) A DIIRON FLAVOPROTEIN REDUCED STATE
403, 2ohiI, 0.8244, 2.92, 0.167, 403, 215, CRYSTAL STRUCTURE OF COENZYME F420H2 OXIDASE (FPRA) A DIIRON FLAVOPROTEIN REDUCED STATE
404, 2ohjD, 0.8242, 2.93, 0.167, 403, 215, CRYSTAL STRUCTURE OF COENZYME F420H2 OXIDASE (FPRA) A DIIRON FLAVOPROTEIN INACTIVE OXIDIZED STATE
405, 2ohjB, 0.8233, 2.95, 0.163, 403, 215, CRYSTAL STRUCTURE OF COENZYME F420H2 OXIDASE (FPRA) A DIIRON FLAVOPROTEIN INACTIVE OXIDIZED STATE
406, 2ohiE, 0.8232, 2.92, 0.167, 403, 215, CRYSTAL STRUCTURE OF COENZYME F420H2 OXIDASE (FPRA) A DIIRON FLAVOPROTEIN REDUCED STATE
407, 2ohiA, 0.8231, 2.93, 0.167, 403, 215, CRYSTAL STRUCTURE OF COENZYME F420H2 OXIDASE (FPRA) A DIIRON FLAVOPROTEIN REDUCED STATE
408, 2ohiH, 0.8223, 2.93, 0.167, 403, 215, CRYSTAL STRUCTURE OF COENZYME F420H2 OXIDASE (FPRA) A DIIRON FLAVOPROTEIN REDUCED STATE
409, 2ohiD, 0.8214, 2.93, 0.167, 403, 215, CRYSTAL STRUCTURE OF COENZYME F420H2 OXIDASE (FPRA) A DIIRON FLAVOPROTEIN REDUCED STATE
410, 2ohhB, 0.8211, 2.92, 0.167, 403, 215, CRYSTAL STRUCTURE OF COENZYME F420H2 OXIDASE (FPRA) A DIIRON FLAVOPROTEIN ACTIVE OXIDIZED STATE
411, 4d02A, 0.8207, 2.80, 0.138, 399, 210, THE CRYSTALLOGRAPHIC STRUCTURE OF FLAVORUBREDOXIN FROM ESCHERICHIA COLI
412, 5lmcA, 0.8201, 2.81, 0.138, 399, 210, OXIDIZED FLAVODIIRON CORE OF ESCHERICHIA COLI FLAVORUBREDOXIN INCLUDING THE FE-4SG ATOMS FROM ITS RUBREDOXIN DOMAIN
413, 1e5dA, 0.8197, 2.83, 0.166, 401, 211, RUBREDOXIN OXYGEN:OXIDOREDUCTASE (ROO) FROM ANAEROBE DESULFOVIBRIO GIGAS
414, 1ycgB, 0.8192, 2.79, 0.137, 398, 211, X-RAY STRUCTURES OF MOORELLA THERMOACETICA FPRA. NOVEL DIIRON SITE STRUCTURE AND MECHANISTIC INSIGHTS INTO A SCAVENGING NITRIC OXIDE REDUCTASE
415, 1ycgD, 0.8191, 2.78, 0.137, 398, 211, X-RAY STRUCTURES OF MOORELLA THERMOACETICA FPRA. NOVEL DIIRON SITE STRUCTURE AND MECHANISTIC INSIGHTS INTO A SCAVENGING NITRIC OXIDE REDUCTASE
416, 1ycgA, 0.8191, 2.78, 0.137, 398, 211, X-RAY STRUCTURES OF MOORELLA THERMOACETICA FPRA. NOVEL DIIRON SITE STRUCTURE AND MECHANISTIC INSIGHTS INTO A SCAVENGING NITRIC OXIDE REDUCTASE
417, 1e5dB, 0.8190, 2.84, 0.166, 401, 211, RUBREDOXIN OXYGEN:OXIDOREDUCTASE (ROO) FROM ANAEROBE DESULFOVIBRIO GIGAS
418, 1ycgC, 0.8189, 2.79, 0.137, 398, 211, X-RAY STRUCTURES OF MOORELLA THERMOACETICA FPRA. NOVEL DIIRON SITE STRUCTURE AND MECHANISTIC INSIGHTS INTO A SCAVENGING NITRIC OXIDE REDUCTASE
419, 1ycfA, 0.8186, 2.78, 0.142, 398, 211, OXIDIZED (DI-FERRIC) FPRA FROM MOORELLA THERMOACETICA
420, 1ycfD, 0.8183, 2.77, 0.137, 398, 211, OXIDIZED (DI-FERRIC) FPRA FROM MOORELLA THERMOACETICA
421, 1ycfC, 0.8179, 2.78, 0.137, 398, 211, OXIDIZED (DI-FERRIC) FPRA FROM MOORELLA THERMOACETICA
422, 1ychA, 0.8178, 2.80, 0.137, 398, 211, X-RAY CRYSTAL STRUCTURES OF MOORELLA THERMOACETICA FPRA. NOVEL DIIRON SITE STRUCTURE AND MECHANISTIC INSIGHTS INTO A SCAVENGING NITRIC OXIDE REDUCTASE
423, 1ychD, 0.8176, 2.80, 0.137, 398, 211, X-RAY CRYSTAL STRUCTURES OF MOORELLA THERMOACETICA FPRA. NOVEL DIIRON SITE STRUCTURE AND MECHANISTIC INSIGHTS INTO A SCAVENGING NITRIC OXIDE REDUCTASE
424, 1ychB, 0.8175, 2.80, 0.137, 398, 211, X-RAY CRYSTAL STRUCTURES OF MOORELLA THERMOACETICA FPRA. NOVEL DIIRON SITE STRUCTURE AND MECHANISTIC INSIGHTS INTO A SCAVENGING NITRIC OXIDE REDUCTASE
425, 1ycfB, 0.8174, 2.78, 0.142, 398, 211, OXIDIZED (DI-FERRIC) FPRA FROM MOORELLA THERMOACETICA
426, 1ychC, 0.8173, 2.80, 0.137, 398, 211, X-RAY CRYSTAL STRUCTURES OF MOORELLA THERMOACETICA FPRA. NOVEL DIIRON SITE STRUCTURE AND MECHANISTIC INSIGHTS INTO A SCAVENGING NITRIC OXIDE REDUCTASE
427, 1vmeB, 0.8164, 2.74, 0.182, 388, 209, CRYSTAL STRUCTURE OF FLAVOPROTEIN (TM0755) FROM THERMOTOGA MARITIMA AT 1.80 A RESOLUTION
428, 1vmeA, 0.8157, 2.76, 0.182, 394, 209, CRYSTAL STRUCTURE OF FLAVOPROTEIN (TM0755) FROM THERMOTOGA MARITIMA AT 1.80 A RESOLUTION
429, 5lldA, 0.8148, 2.82, 0.139, 398, 209, FLAVODIIRON CORE OF ESCHERICHIA COLI FLAVORUBREDOXIN IN THE REDUCED FORM.
430, 2yheE, 0.8125, 2.58, 0.131, 634, 206, STRUCTURE DETERMINATION OF THE STEREOSELECTIVE INVERTING SEC-ALKYLSULFATASE PISA1 FROM PSEUDOMONAS SP.
431, 4av7E, 0.8123, 2.59, 0.131, 634, 206, STRUCTURE DETERMINATION OF THE DOUBLE MUTANT S233Y F250G FROM THE SEC-ALKYL SULFATASE PISA1
432, 2yheD, 0.8123, 2.58, 0.131, 634, 206, STRUCTURE DETERMINATION OF THE STEREOSELECTIVE INVERTING SEC-ALKYLSULFATASE PISA1 FROM PSEUDOMONAS SP.
433, 2yheB, 0.8119, 2.59, 0.131, 634, 206, STRUCTURE DETERMINATION OF THE STEREOSELECTIVE INVERTING SEC-ALKYLSULFATASE PISA1 FROM PSEUDOMONAS SP.
434, 2cg2A, 0.8117, 2.59, 0.107, 629, 206, CRYSTAL STRUCTURE OF SDSA1 AN ALKYLSULFATASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH SULFATE
435, 5aijA, 0.8116, 2.60, 0.112, 630, 206, P. AERUGINOSA SDSA HEXAGONAL POLYMORPH
436, 4av7C, 0.8115, 2.59, 0.131, 634, 206, STRUCTURE DETERMINATION OF THE DOUBLE MUTANT S233Y F250G FROM THE SEC-ALKYL SULFATASE PISA1
437, 4av7A, 0.8115, 2.59, 0.131, 634, 206, STRUCTURE DETERMINATION OF THE DOUBLE MUTANT S233Y F250G FROM THE SEC-ALKYL SULFATASE PISA1
438, 2yheF, 0.8114, 2.59, 0.131, 634, 206, STRUCTURE DETERMINATION OF THE STEREOSELECTIVE INVERTING SEC-ALKYLSULFATASE PISA1 FROM PSEUDOMONAS SP.
439, 2yheA, 0.8114, 2.59, 0.131, 639, 206, STRUCTURE DETERMINATION OF THE STEREOSELECTIVE INVERTING SEC-ALKYLSULFATASE PISA1 FROM PSEUDOMONAS SP.
440, 4axhA, 0.8112, 2.57, 0.132, 631, 205, STRUCTURE AND MECHANISM OF THE FIRST INVERTING ALKYLSULFATASE SPECIFIC FOR SECONDARY ALKYLSULFATASES
441, 2yheC, 0.8111, 2.60, 0.131, 634, 206, STRUCTURE DETERMINATION OF THE STEREOSELECTIVE INVERTING SEC-ALKYLSULFATASE PISA1 FROM PSEUDOMONAS SP.
442, 4av7F, 0.8105, 2.61, 0.131, 634, 206, STRUCTURE DETERMINATION OF THE DOUBLE MUTANT S233Y F250G FROM THE SEC-ALKYL SULFATASE PISA1
443, 4axhB, 0.8104, 2.60, 0.131, 631, 206, STRUCTURE AND MECHANISM OF THE FIRST INVERTING ALKYLSULFATASE SPECIFIC FOR SECONDARY ALKYLSULFATASES
444, 2cfzA, 0.8104, 2.61, 0.112, 630, 206, CRYSTAL STRUCTURE OF SDSA1 AN ALKYLSULFATASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH 1-DODECANOL
445, 5ajlB, 0.8098, 2.56, 0.117, 630, 205, SDSA SULFATASE TETRAGONAL
446, 4av7D, 0.8097, 2.62, 0.131, 634, 206, STRUCTURE DETERMINATION OF THE DOUBLE MUTANT S233Y F250G FROM THE SEC-ALKYL SULFATASE PISA1
447, 5a23B, 0.8095, 2.59, 0.112, 627, 205, SDSA SULFATASE TRICLINIC FORM
448, 5ajlA, 0.8092, 2.62, 0.107, 630, 206, SDSA SULFATASE TETRAGONAL
449, 4av7B, 0.8080, 2.58, 0.132, 637, 205, STRUCTURE DETERMINATION OF THE DOUBLE MUTANT S233Y F250G FROM THE SEC-ALKYL SULFATASE PISA1
450, 2cfuA, 0.8076, 2.74, 0.107, 627, 206, CRYSTAL STRUCTURE OF SDSA1 AN ALKYLSULFATASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH 1-DECANE-SULFONIC- ACID.
451, 5a23A, 0.8074, 2.73, 0.112, 627, 206, SDSA SULFATASE TRICLINIC FORM
452, 5a23D, 0.8070, 2.74, 0.107, 627, 206, SDSA SULFATASE TRICLINIC FORM
453, 5a23C, 0.8067, 2.63, 0.112, 627, 205, SDSA SULFATASE TRICLINIC FORM
454, 6ao1D, 0.8065, 2.83, 0.148, 352, 209, CRYSTAL STRUCTURE OF A BETA-LACTAMASE FROM BURKHOLDERIA PHYMATUM
455, 6ao1C, 0.8062, 2.84, 0.153, 353, 209, CRYSTAL STRUCTURE OF A BETA-LACTAMASE FROM BURKHOLDERIA PHYMATUM
456, 6ao1B, 0.8060, 2.84, 0.153, 353, 209, CRYSTAL STRUCTURE OF A BETA-LACTAMASE FROM BURKHOLDERIA PHYMATUM
457, 6ao1A, 0.8054, 2.87, 0.143, 354, 210, CRYSTAL STRUCTURE OF A BETA-LACTAMASE FROM BURKHOLDERIA PHYMATUM
458, 5u8oA, 0.8051, 2.88, 0.133, 352, 210, CRYSTAL STRUCTURE OF BETA-LACTAMASE DOMAIN PROTEIN FROM BURKHOLDERIA MULTIVORANS
459, 4nurA, 0.8051, 2.64, 0.165, 633, 206, CRYSTAL STRUCTURE OF THERMOSTABLE ALKYLSULFATASE SDSAP FROM PSEUDOMONAS SP. S9
460, 4nurB, 0.8047, 2.67, 0.170, 633, 206, CRYSTAL STRUCTURE OF THERMOSTABLE ALKYLSULFATASE SDSAP FROM PSEUDOMONAS SP. S9
461, 5i0pC, 0.8045, 2.88, 0.138, 339, 210, CRYSTAL STRUCTURE OF A BETA-LACTAMASE DOMAIN PROTEIN FROM BURKHOLDERIA AMBIFARIA
462, 5u8oC, 0.8044, 2.94, 0.137, 349, 211, CRYSTAL STRUCTURE OF BETA-LACTAMASE DOMAIN PROTEIN FROM BURKHOLDERIA MULTIVORANS
463, 5u8oB, 0.8029, 2.84, 0.129, 360, 209, CRYSTAL STRUCTURE OF BETA-LACTAMASE DOMAIN PROTEIN FROM BURKHOLDERIA MULTIVORANS
464, 5i0pB, 0.8026, 2.96, 0.137, 323, 211, CRYSTAL STRUCTURE OF A BETA-LACTAMASE DOMAIN PROTEIN FROM BURKHOLDERIA AMBIFARIA
465, 5i0pD, 0.8019, 2.98, 0.137, 344, 211, CRYSTAL STRUCTURE OF A BETA-LACTAMASE DOMAIN PROTEIN FROM BURKHOLDERIA AMBIFARIA
466, 5u8oD, 0.8018, 2.96, 0.137, 354, 211, CRYSTAL STRUCTURE OF BETA-LACTAMASE DOMAIN PROTEIN FROM BURKHOLDERIA MULTIVORANS
467, 5i0pA, 0.8013, 2.93, 0.138, 322, 210, CRYSTAL STRUCTURE OF A BETA-LACTAMASE DOMAIN PROTEIN FROM BURKHOLDERIA AMBIFARIA
468, 2q9uA, 0.7972, 3.01, 0.138, 409, 210, CRYSTAL STRUCTURE OF THE FLAVODIIRON PROTEIN FROM GIARDIA INTESTINALIS
469, 2q9uB, 0.7954, 3.08, 0.137, 407, 211, CRYSTAL STRUCTURE OF THE FLAVODIIRON PROTEIN FROM GIARDIA INTESTINALIS
470, 2q0jA, 0.7949, 2.70, 0.153, 310, 202, STRUCTURE OF PSEUDOMONAS QUINOLONE SIGNAL RESPONSE PROTEIN PQSE
471, 2q0jB, 0.7939, 2.71, 0.153, 301, 202, STRUCTURE OF PSEUDOMONAS QUINOLONE SIGNAL RESPONSE PROTEIN PQSE
472, 5hisA, 0.7928, 2.60, 0.154, 298, 201, CRYSTAL STRUCTURE OF PQS RESPONSE PROTEIN PQSE IN COMPLEX WITH 3- METHYLTHIOPHENE-2-CARBOXYLIC ACID
473, 5hiqA, 0.7927, 2.59, 0.154, 300, 201, CRYSTAL STRUCTURE OF PQS RESPONSE PROTEIN PQSE IN COMPLEX WITH 2-(1H- PYRROL-1-YL)BENZOIC ACID
474, 5hioA, 0.7927, 2.60, 0.154, 301, 201, CRYSTAL STRUCTURE OF PQS RESPONSE PROTEIN PQSE IN COMPLEX WITH 2- AMINOBENZOYLACETATE
475, 5hipA, 0.7926, 2.61, 0.154, 298, 201, CRYSTAL STRUCTURE OF PQS RESPONSE PROTEIN PQSE IN COMPLEX WITH 2- (PYRIDIN-3-YL)BENZOIC ACID
476, 4fekA, 0.7924, 3.04, 0.130, 249, 208, CRYSTAL STRUCTURE OF PUTATIVE DIFLAVIN FLAVOPROTEIN A 5 (FRAGMENT 1- 254) FROM NOSTOC SP. PCC 7120 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET NSR435A  NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET NSR435A
477, 3dh8A, 0.7923, 2.60, 0.154, 299, 201, STRUCTURE OF PSEUDOMONAS QUINOLONE SIGNAL RESPONSE PROTEIN PQSE
478, 2q0iA, 0.7923, 2.60, 0.154, 300, 201, STRUCTURE OF PSEUDOMONAS QUINOLONE SIGNAL RESPONSE PROTEIN PQSE
479, 2vw8A, 0.7922, 2.61, 0.149, 299, 201, CRYSTAL STRUCTURE OF QUINOLONE SIGNAL RESPONSE PROTEIN PQSE FROM PSEUDOMONAS AERUGINOSA
480, 4ad9C, 0.7920, 3.13, 0.166, 285, 205, CRYSTAL STRUCTURE OF HUMAN LACTB2.
481, 4ad9F, 0.7907, 3.16, 0.165, 285, 206, CRYSTAL STRUCTURE OF HUMAN LACTB2.
482, 4ad9E, 0.7897, 3.06, 0.167, 284, 204, CRYSTAL STRUCTURE OF HUMAN LACTB2.
483, 4ad9B, 0.7895, 3.06, 0.167, 285, 204, CRYSTAL STRUCTURE OF HUMAN LACTB2.
484, 4ad9D, 0.7890, 3.06, 0.167, 288, 204, CRYSTAL STRUCTURE OF HUMAN LACTB2.
485, 4ad9A, 0.7884, 3.11, 0.166, 288, 205, CRYSTAL STRUCTURE OF HUMAN LACTB2.
486, 4fekB, 0.7879, 3.17, 0.120, 245, 208, CRYSTAL STRUCTURE OF PUTATIVE DIFLAVIN FLAVOPROTEIN A 5 (FRAGMENT 1- 254) FROM NOSTOC SP. PCC 7120 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET NSR435A  NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET NSR435A
487, 2h6aB, 0.7829, 2.45, 0.158, 266, 196, CRYSTAL STRUCTURE OF THE ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (MONO ZINC FORM)
488, 5evbA, 0.7828, 2.45, 0.158, 266, 196, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE L1 IN COMPLEX WITH THE BISTHIAZOLIDINE INHIBITOR D-CS319
489, 2fu6B, 0.7827, 2.44, 0.163, 266, 196, ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (APO FORM)
490, 5hh5A, 0.7826, 2.45, 0.158, 266, 196, CRYSTAL STRUCTURE OF B3 METALLO-BETA-LACTAMASE L1 COMPLEXED WITH A PHOSPHONATE-BASED INHIBITOR
491, 5hh6A, 0.7825, 2.46, 0.158, 266, 196, CRYSTAL STRUCTURE OF B3 METALLO-BETA-LACTAMASE L1 IN COMPLEX WITH A PHOSPHONATE-BASED INHIBITOR
492, 2h6aA, 0.7825, 2.46, 0.158, 266, 196, CRYSTAL STRUCTURE OF THE ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (MONO ZINC FORM)
493, 2fm6B, 0.7824, 2.46, 0.158, 266, 196, ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (NATIVE FORM)
494, 2fu8B, 0.7823, 2.45, 0.163, 266, 196, ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (D-CAPTOPRIL COMPLEX)
495, 2fu7B, 0.7823, 2.46, 0.158, 266, 196, ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (CU- SUBSTITUTED FORM)
496, 2fu6A, 0.7822, 2.45, 0.158, 266, 196, ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (APO FORM)
497, 5evkA, 0.7821, 2.46, 0.158, 266, 196, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE L1 IN COMPLEX WITH THE BISTHIAZOLIDINE INHIBITOR L-CS319
498, 2fu9A, 0.7821, 2.45, 0.158, 266, 196, ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (MP2 INHIBITOR COMPLEX)
499, 2fu8A, 0.7821, 2.46, 0.158, 266, 196, ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (D-CAPTOPRIL COMPLEX)
500, 5evdA, 0.7820, 2.45, 0.158, 267, 196, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE L1 IN COMPLEX WITH THE BISTHIAZOLIDINE INHIBITOR D-VC26
501, 1smlA, 0.7820, 2.46, 0.158, 266, 196, METALLO BETA LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA
502, 2qdtA, 0.7819, 2.46, 0.158, 266, 196, STRUCTURAL BASIS FOR THE BROAD-SPECTRUM INHIBITION OF METALLO-{BETA}- LACTAMASES: L1- IS38 COMPLEX
503, 2qinD, 0.7818, 2.47, 0.153, 265, 196, STENOTROPHOMONAS MALTOPHILIA L1 METALLO-BETA-LACTAMASE ASP-120 CYS MUTANT
504, 5dpxB, 0.7816, 2.46, 0.158, 266, 196, 124-TRIAZOLE-3-THIONE COMPOUNDS AS INHIBITORS OF L1 DI-ZINC METALLO-BETA-LACTAMASES.
505, 2aioA, 0.7816, 2.45, 0.163, 266, 196, METALLO BETA LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA COMPLEXED WITH HYDROLYZED MOXALACTAM
506, 2fu9B, 0.7815, 2.54, 0.157, 266, 197, ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (MP2 INHIBITOR COMPLEX)
507, 5dpxA, 0.7813, 2.46, 0.158, 266, 196, 124-TRIAZOLE-3-THIONE COMPOUNDS AS INHIBITORS OF L1 DI-ZINC METALLO-BETA-LACTAMASES.
508, 2fm6A, 0.7813, 2.47, 0.158, 266, 196, ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (NATIVE FORM)
509, 2hb9A, 0.7812, 2.46, 0.158, 266, 196, CRYSTAL STRUCTURE OF THE ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (INHIBITOR 3)
510, 2qjsA, 0.7804, 2.52, 0.163, 248, 196, STENOTROPHOMONAS MALTOPHILIA L1 METALLO-BETA-LACTAMASE ASP-120 ASN MUTANT
511, 2qinC, 0.7804, 2.49, 0.153, 265, 196, STENOTROPHOMONAS MALTOPHILIA L1 METALLO-BETA-LACTAMASE ASP-120 CYS MUTANT
512, 2gfkB, 0.7803, 2.47, 0.158, 266, 196, CRYSTAL STRUCTURE OF THE ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (INHIBITOR 2)
513, 2fu7A, 0.7803, 2.47, 0.158, 266, 196, ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (CU- SUBSTITUTED FORM)
514, 2qinA, 0.7801, 2.57, 0.152, 263, 197, STENOTROPHOMONAS MALTOPHILIA L1 METALLO-BETA-LACTAMASE ASP-120 CYS MUTANT
515, 2zo4A, 0.7797, 2.78, 0.133, 301, 203, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE FAMILY PROTEIN TTHA1429 FROM THERMUS THERMOPHILUS HB8
516, 2cg3A, 0.7796, 2.99, 0.119, 617, 201, CRYSTAL STRUCTURE OF SDSA1 AN ALKYLSULFATASE FROM PSEUDOMONAS AERUGINOSA.
517, 2qjsC, 0.7795, 2.45, 0.159, 248, 195, STENOTROPHOMONAS MALTOPHILIA L1 METALLO-BETA-LACTAMASE ASP-120 ASN MUTANT
518, 2gfkA, 0.7795, 2.48, 0.158, 266, 196, CRYSTAL STRUCTURE OF THE ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (INHIBITOR 2)
519, 2gfjB, 0.7795, 2.48, 0.158, 266, 196, CRYSTAL STRUCTURE OF THE ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (INHIBITOR 1)
520, 2gfjA, 0.7794, 2.48, 0.158, 266, 196, CRYSTAL STRUCTURE OF THE ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (INHIBITOR 1)
521, 2qjsB, 0.7792, 2.54, 0.163, 248, 196, STENOTROPHOMONAS MALTOPHILIA L1 METALLO-BETA-LACTAMASE ASP-120 ASN MUTANT
522, 2qinB, 0.7783, 2.51, 0.153, 264, 196, STENOTROPHOMONAS MALTOPHILIA L1 METALLO-BETA-LACTAMASE ASP-120 CYS MUTANT
523, 2qjsD, 0.7779, 2.46, 0.164, 248, 195, STENOTROPHOMONAS MALTOPHILIA L1 METALLO-BETA-LACTAMASE ASP-120 ASN MUTANT
524, 1k07B, 0.7769, 2.54, 0.122, 262, 197, NATIVE FEZ-1 METALLO-BETA-LACTAMASE FROM LEGIONELLA GORMANII
525, 5wckB, 0.7767, 2.55, 0.122, 263, 197, NATIVE FEZ-1 METALLO-BETA-LACTAMASE FROM LEGIONELLA GORMANII 
526, 1k07A, 0.7766, 2.55, 0.122, 262, 197, NATIVE FEZ-1 METALLO-BETA-LACTAMASE FROM LEGIONELLA GORMANII
527, 5wckA, 0.7762, 2.55, 0.117, 263, 197, NATIVE FEZ-1 METALLO-BETA-LACTAMASE FROM LEGIONELLA GORMANII 
528, 1l9yB, 0.7762, 2.54, 0.122, 263, 197, FEZ-1-Y228A A MUTANT OF THE METALLO-BETA-LACTAMASE FROM LEGIONELLA GORMANII
529, 1jt1A, 0.7760, 2.55, 0.117, 262, 197, FEZ-1 METALLO-BETA-LACTAMASE FROM LEGIONELLA GORMANII MODELLED WITH D- CAPTOPRIL
530, 5w90A, 0.7757, 2.55, 0.117, 263, 197, FEZ-1 METALLO-BETA-LACTAMASE FROM LEGIONELLA GORMANII MODELLED WITH UNKNOWN LIGAND 
531, 1l9yA, 0.7747, 2.56, 0.122, 263, 197, FEZ-1-Y228A A MUTANT OF THE METALLO-BETA-LACTAMASE FROM LEGIONELLA GORMANII
532, 4awzB, 0.7741, 2.55, 0.128, 267, 196, AIM-1-3MOL. CRYSTAL STRUCTURE OF THE MOBILE METALLO-BETA-LACTAMASE AIM-1 FROM PSEUDOMONAS AERUGINOSA: INSIGHTS INTO ANTIBIOTIC BINDING AND THE ROLE OF GLN157
533, 4awzA, 0.7736, 2.60, 0.122, 269, 196, AIM-1-3MOL. CRYSTAL STRUCTURE OF THE MOBILE METALLO-BETA-LACTAMASE AIM-1 FROM PSEUDOMONAS AERUGINOSA: INSIGHTS INTO ANTIBIOTIC BINDING AND THE ROLE OF GLN157
534, 4p62A, 0.7726, 2.58, 0.128, 269, 196, DIRECTED EVOLUTION OF A B3 METALLO-BETA-LACTAMASE AIM-1
535, 4awyB, 0.7720, 2.58, 0.128, 270, 196, CRYSTAL STRUCTURE OF THE MOBILE METALLO-BETA-LACTAMASE AIM-1 FROM PSEUDOMONAS AERUGINOSA: INSIGHTS INTO ANTIBIOTIC BINDING AND THE ROLE OF GLN157
536, 4ax0B, 0.7716, 2.59, 0.128, 270, 196, Q157A MUTANT. CRYSTAL STRUCTURE OF THE MOBILE METALLO-BETA-LACTAMASE AIM-1 FROM PSEUDOMONAS AERUGINOSA: INSIGHTS INTO ANTIBIOTIC BINDING AND THE ROLE OF GLN157
537, 4awzC, 0.7716, 2.58, 0.128, 269, 196, AIM-1-3MOL. CRYSTAL STRUCTURE OF THE MOBILE METALLO-BETA-LACTAMASE AIM-1 FROM PSEUDOMONAS AERUGINOSA: INSIGHTS INTO ANTIBIOTIC BINDING AND THE ROLE OF GLN157
538, 4pdxB, 0.7714, 2.64, 0.147, 603, 197, CRYSTAL STRUCTURE OF ESCHERCHIA COLI UNCHARACTERIZED PROTEIN YJCS
539, 4ax1B, 0.7712, 2.59, 0.128, 270, 196, Q157N MUTANT. CRYSTAL STRUCTURE OF THE MOBILE METALLO-BETA- LACTAMASE AIM-1 FROM PSEUDOMONAS AERUGINOSA: INSIGHTS INTO ANTIBIOTIC BINDING AND THE ROLE OF GLN157
540, 4pdxA, 0.7706, 2.65, 0.147, 606, 197, CRYSTAL STRUCTURE OF ESCHERCHIA COLI UNCHARACTERIZED PROTEIN YJCS
541, 5iqkA, 0.7685, 2.61, 0.138, 269, 196, RM3 METALLO-BETA-LACTAMASE
542, 5iqkB, 0.7664, 2.68, 0.138, 270, 196, RM3 METALLO-BETA-LACTAMASE
543, 5aebA, 0.7662, 2.66, 0.128, 264, 196, CRYSTAL STRUCTURE OF THE CLASS B3 DI-ZINC METALLO-BETA- LACTAMASE LRA-12 FROM AN ALASKAN SOIL METAGENOME.
544, 2gmnB, 0.7660, 2.65, 0.137, 264, 197, CRYSTAL STRUCTURE OF BJP-1 A SUBCLASS B3 METALLO-BETA-LACTAMASE OF BRADYRHIZOBIUM JAPONICUM
545, 3lvzB, 0.7659, 2.65, 0.137, 273, 197, NEW REFINEMENT OF THE CRYSTAL STRUCTURE OF BJP-1 A SUBCLASS B3 METALLO-BETA-LACTAMASE OF BRADYRHIZOBIUM JAPONICUM
546, 3lvzA, 0.7659, 2.65, 0.137, 272, 197, NEW REFINEMENT OF THE CRYSTAL STRUCTURE OF BJP-1 A SUBCLASS B3 METALLO-BETA-LACTAMASE OF BRADYRHIZOBIUM JAPONICUM
547, 2gmnA, 0.7659, 2.65, 0.137, 264, 197, CRYSTAL STRUCTURE OF BJP-1 A SUBCLASS B3 METALLO-BETA-LACTAMASE OF BRADYRHIZOBIUM JAPONICUM
548, 5aebB, 0.7654, 2.67, 0.128, 266, 196, CRYSTAL STRUCTURE OF THE CLASS B3 DI-ZINC METALLO-BETA- LACTAMASE LRA-12 FROM AN ALASKAN SOIL METAGENOME.
549, 3m8tB, 0.7653, 2.67, 0.132, 263, 197, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CLASS B3 BETA-LACTAMASE BJP-1 AND 4-NITROBENZENE-SULFONAMIDE
550, 5wcmB, 0.7651, 2.67, 0.132, 263, 197, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CLASS B3 BETA-LACTAMASE BJP-1 AND 4-NITROBENZENE-SULFONAMIDE - NEW REFINEMENT
551, 5njwB, 0.7650, 2.66, 0.137, 274, 197, CRYSTAL STRUCTURE OF BJP-1 METALLO BETA-LACTAMASE IN COMPLEX WITH BORIC ACID
552, 3m8tA, 0.7650, 2.66, 0.137, 263, 197, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CLASS B3 BETA-LACTAMASE BJP-1 AND 4-NITROBENZENE-SULFONAMIDE
553, 5wcmA, 0.7648, 2.66, 0.137, 263, 197, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CLASS B3 BETA-LACTAMASE BJP-1 AND 4-NITROBENZENE-SULFONAMIDE - NEW REFINEMENT
554, 5nggA, 0.7648, 2.66, 0.137, 274, 197, CRYSTAL STRUCTURE OF THE SUBCLASS B3 METALLO-BETA-LACTAMASE BJP-1 IN COMPLEX WITH ACETATE ANION
555, 3vqzA, 0.7646, 2.65, 0.133, 257, 196, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE SMB-1 IN A COMPLEX WITH MERCAPTOACETIC ACID
556, 5njwA, 0.7645, 2.67, 0.137, 274, 197, CRYSTAL STRUCTURE OF BJP-1 METALLO BETA-LACTAMASE IN COMPLEX WITH BORIC ACID
557, 5axrA, 0.7644, 2.66, 0.133, 259, 196, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE SMB-1 BOUND TO 2- MERCAPTOETHANESULFONATE
558, 6e0sA, 0.7643, 2.66, 0.133, 264, 196, CRYSTAL STRUCTURE OF MEM-A1; A SUBCLASS B3 METALLO-BETA-LACTAMASE ISOLATED FROM A SOIL METAGENOME LIBRARY 
559, 5ayaA, 0.7642, 2.64, 0.138, 259, 196, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE SMB-1 BOUND TO L-CAPTOPRIL
560, 5nggB, 0.7641, 2.67, 0.137, 274, 197, CRYSTAL STRUCTURE OF THE SUBCLASS B3 METALLO-BETA-LACTAMASE BJP-1 IN COMPLEX WITH ACETATE ANION
561, 3t9mA, 0.7635, 2.21, 0.204, 206, 181, CRYSTAL STRUCTURE OF MUTANT C221D OF CARBAPENEMASE CPHA FROM AEROMONAS HYDROPHILA
562, 3vpeA, 0.7630, 2.68, 0.138, 259, 196, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE SMB-1
563, 5k0wA, 0.7626, 2.69, 0.158, 270, 196, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE GOB-18 FROM ELIZABETHKINGIA MENINGOSEPTICA
564, 5axoA, 0.7624, 2.66, 0.138, 259, 196, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE SMB-1 BOUND TO HYDROLYZED MEROPENEM
565, 4yskB, 0.7623, 3.04, 0.144, 294, 201, CRYSTAL STRUCTURE OF APO-FORM SDOA FROM PSEUDOMONAS PUTIDA
566, 4yskA, 0.7623, 3.05, 0.144, 294, 201, CRYSTAL STRUCTURE OF APO-FORM SDOA FROM PSEUDOMONAS PUTIDA
567, 4yslB, 0.7620, 3.04, 0.144, 294, 201, CRYSTAL STRUCTURE OF SDOA FROM PSEUDOMONAS PUTIDA IN COMPLEX WITH GLUTATHIONE
568, 5b15A, 0.7597, 2.74, 0.138, 259, 196, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE SMB-1 BOUND TO HYDROLYZED DORIPENEM
569, 3sw3A, 0.7597, 2.22, 0.206, 205, 180, EDTA-FREE CRYSTAL STRUCTURE OF THE MUTANT C221D OF CARBAPENEMASE CPHA FROM AEROMONAS HYDROPHILA
570, 5b1uA, 0.7593, 2.74, 0.138, 259, 196, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE SMB-1 BOUND TO HYDROLYZED IMIPENEM
571, 5k0wB, 0.7590, 2.75, 0.158, 271, 196, CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE GOB-18 FROM ELIZABETHKINGIA MENINGOSEPTICA
572, 4yslA, 0.7589, 3.07, 0.144, 293, 201, CRYSTAL STRUCTURE OF SDOA FROM PSEUDOMONAS PUTIDA IN COMPLEX WITH GLUTATHIONE
573, 5ve5B, 0.7563, 2.58, 0.154, 349, 188, CRYSTAL STRUCTURE OF PERSULFIDE DIOXYGENASE RHODANESE FUSION PROTEIN WITH RHODANESE DOMAIN INACTIVATING MUTATION (C314S) FROM BURKHOLDERIA PHYTOFIRMANS IN COMPLEX WITH GLUTATHIONE
574, 1p9eA, 0.7563, 3.53, 0.122, 294, 205, CRYSTAL STRUCTURE ANALYSIS OF METHYL PARATHION HYDROLASE FROM PSEUDOMONAS SP WBC-3
575, 4efzA, 0.7560, 3.13, 0.155, 295, 200, CRYSTAL STRUCTURE OF A HYPOTHETICAL METALLO-BETA-LACTAMASE FROM BURKHOLDERIA PSEUDOMALLEI
576, 5ve5A, 0.7559, 2.59, 0.154, 350, 188, CRYSTAL STRUCTURE OF PERSULFIDE DIOXYGENASE RHODANESE FUSION PROTEIN WITH RHODANESE DOMAIN INACTIVATING MUTATION (C314S) FROM BURKHOLDERIA PHYTOFIRMANS IN COMPLEX WITH GLUTATHIONE
577, 5ve4A, 0.7555, 2.59, 0.154, 349, 188, CRYSTAL STRUCTURE OF PERSULFIDE DIOXYGENASE-RHODANESE FUSION PROTEIN WITH RHODANESE DOMAIN INACTIVATING MUTATION (C314S) FROM BURKHOLDERIA PHYTOFIRMANS
578, 5ve4B, 0.7554, 2.59, 0.154, 349, 188, CRYSTAL STRUCTURE OF PERSULFIDE DIOXYGENASE-RHODANESE FUSION PROTEIN WITH RHODANESE DOMAIN INACTIVATING MUTATION (C314S) FROM BURKHOLDERIA PHYTOFIRMANS
579, 5ve3A, 0.7552, 2.59, 0.154, 347, 188, CRYSTAL STRUCTURE OF WILD-TYPE PERSULFIDE DIOXYGENASE-RHODANESE FUSION PROTEIN FROM BURKHOLDERIA PHYTOFIRMANS
580, 5ve3B, 0.7551, 2.60, 0.154, 347, 188, CRYSTAL STRUCTURE OF WILD-TYPE PERSULFIDE DIOXYGENASE-RHODANESE FUSION PROTEIN FROM BURKHOLDERIA PHYTOFIRMANS
581, 2gcuA, 0.7551, 2.54, 0.139, 243, 187, X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT1G53580
582, 1p9eB, 0.7547, 3.48, 0.123, 294, 204, CRYSTAL STRUCTURE ANALYSIS OF METHYL PARATHION HYDROLASE FROM PSEUDOMONAS SP WBC-3
583, 4efzB, 0.7546, 3.03, 0.162, 289, 198, CRYSTAL STRUCTURE OF A HYPOTHETICAL METALLO-BETA-LACTAMASE FROM BURKHOLDERIA PSEUDOMALLEI
584, 5ve4C, 0.7543, 2.61, 0.154, 347, 188, CRYSTAL STRUCTURE OF PERSULFIDE DIOXYGENASE-RHODANESE FUSION PROTEIN WITH RHODANESE DOMAIN INACTIVATING MUTATION (C314S) FROM BURKHOLDERIA PHYTOFIRMANS
585, 2gcuC, 0.7542, 2.57, 0.139, 243, 187, X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT1G53580
586, 5ve5C, 0.7540, 2.61, 0.154, 347, 188, CRYSTAL STRUCTURE OF PERSULFIDE DIOXYGENASE RHODANESE FUSION PROTEIN WITH RHODANESE DOMAIN INACTIVATING MUTATION (C314S) FROM BURKHOLDERIA PHYTOFIRMANS IN COMPLEX WITH GLUTATHIONE
587, 4chlB, 0.7533, 2.54, 0.155, 236, 187, HUMAN ETHYLMALONIC ENCEPHALOPATHY PROTEIN 1 (HETHE1)
588, 5hifB, 0.7527, 3.55, 0.122, 299, 205, CRYSTAL STRUCTURE OF A RECONSTRUCTED LACTONASE ANCESTOR ANC1-MPH OF THE BACTERIAL METHYL PARATHION HYDROLASE MPH.
589, 5hifA, 0.7519, 3.58, 0.122, 299, 205, CRYSTAL STRUCTURE OF A RECONSTRUCTED LACTONASE ANCESTOR ANC1-MPH OF THE BACTERIAL METHYL PARATHION HYDROLASE MPH.
590, 2gcuB, 0.7518, 2.63, 0.133, 236, 188, X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT1G53580
591, 4chlA, 0.7517, 2.56, 0.155, 233, 187, HUMAN ETHYLMALONIC ENCEPHALOPATHY PROTEIN 1 (HETHE1)
592, 2gcuD, 0.7514, 2.64, 0.133, 236, 188, X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT1G53580
593, 2p18A, 0.7489, 2.72, 0.165, 283, 194, CRYSTAL STRUCTURE OF THE LEISHMANIA INFANTUM GLYOXALASE II
594, 2xf4A, 0.7479, 2.64, 0.159, 210, 189, CRYSTAL STRUCTURE OF SALMONELLA ENTERICA SEROVAR TYPHIMURIUM YCBL
595, 2p1eA, 0.7471, 2.74, 0.165, 279, 194, CRYSTAL STRUCTURE OF THE LEISHMANIA INFANTUM GLYOXALASE II WITH D- LACTATE AT THE ACTIVE SITE
596, 4zo3A, 0.7444, 3.61, 0.150, 294, 206, AIDC A DIZINC QUORUM-QUENCHING LACTONASE IN COMPLEX WITH A PRODUCT N-HEXNOYL-L-HOMOSERINE
597, 4zo3B, 0.7435, 3.57, 0.156, 294, 205, AIDC A DIZINC QUORUM-QUENCHING LACTONASE IN COMPLEX WITH A PRODUCT N-HEXNOYL-L-HOMOSERINE
598, 4zo2A, 0.7428, 3.56, 0.156, 293, 205, AIDC A DIZINC QUORUM-QUENCHING LACTONASE
599, 2p97A, 0.7428, 2.66, 0.142, 198, 190, CRYSTAL STRUCTURE OF A PUTATIVE METAL-DEPENDENT HYDROLASE (AVA_3068) FROM ANABAENA VARIABILIS ATCC 29413 AT 1.65 A RESOLUTION
600, 4zo2B, 0.7426, 3.56, 0.156, 294, 205, AIDC A DIZINC QUORUM-QUENCHING LACTONASE
601, 1xm8B, 0.7413, 2.45, 0.183, 254, 186, X-RAY STRUCTURE OF GLYOXALASE II FROM ARABIDOPSIS THALIANA GENE AT2G31350
602, 4o98A, 0.7408, 3.61, 0.142, 306, 204, CRYSTAL STRUCTURE OF PSEUDOMONAS OLEOVORANS POOPH MUTANT H250I/I263W
603, 1xm8A, 0.7408, 2.45, 0.183, 254, 186, X-RAY STRUCTURE OF GLYOXALASE II FROM ARABIDOPSIS THALIANA GENE AT2G31350
604, 4o98B, 0.7406, 3.64, 0.141, 307, 205, CRYSTAL STRUCTURE OF PSEUDOMONAS OLEOVORANS POOPH MUTANT H250I/I263W
605, 2p97B, 0.7397, 2.68, 0.142, 198, 190, CRYSTAL STRUCTURE OF A PUTATIVE METAL-DEPENDENT HYDROLASE (AVA_3068) FROM ANABAENA VARIABILIS ATCC 29413 AT 1.65 A RESOLUTION
606, 2q42A, 0.7386, 2.46, 0.194, 254, 186, ENSEMBLE REFINEMENT OF THE PROTEIN CRYSTAL STRUCTURE OF GLYOXALASE II FROM ARABIDOPSIS THALIANA GENE AT2G31350
607, 2q42B, 0.7383, 2.49, 0.183, 254, 186, ENSEMBLE REFINEMENT OF THE PROTEIN CRYSTAL STRUCTURE OF GLYOXALASE II FROM ARABIDOPSIS THALIANA GENE AT2G31350
608, 4ysbA, 0.7381, 2.59, 0.162, 225, 185, CRYSTAL STRUCTURE OF ETHE1 FROM MYXOCOCCUS XANTHUS
609, 4ysbB, 0.7379, 2.59, 0.162, 225, 185, CRYSTAL STRUCTURE OF ETHE1 FROM MYXOCOCCUS XANTHUS
610, 3r2uC, 0.7349, 3.10, 0.167, 338, 192, 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE FROM STAPHYLOCOCCUS AUREUS SUBSP. AUREUS COL
611, 4xukB, 0.7348, 3.59, 0.158, 291, 203, CRYSTAL STRUCTURE OF HYDROLASE ABOPH IN BETA LACTAMASE SUPERFAMILY
612, 3r2uA, 0.7344, 3.13, 0.156, 348, 192, 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE FROM STAPHYLOCOCCUS AUREUS SUBSP. AUREUS COL
613, 4xukA, 0.7342, 3.63, 0.147, 291, 204, CRYSTAL STRUCTURE OF HYDROLASE ABOPH IN BETA LACTAMASE SUPERFAMILY
614, 3r2uD, 0.7340, 3.08, 0.162, 337, 191, 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE FROM STAPHYLOCOCCUS AUREUS SUBSP. AUREUS COL
615, 3r2uB, 0.7328, 3.13, 0.156, 336, 192, 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE FROM STAPHYLOCOCCUS AUREUS SUBSP. AUREUS COL
616, 2zwrB, 0.7307, 2.83, 0.202, 207, 188, CRYSTAL STRUCTURE OF TTHA1623 FROM THERMUS THERMOPHILUS HB8
617, 3tp9A, 0.7252, 3.12, 0.168, 466, 190, CRYSTAL STRUCTURE OF ALICYCLOBACILLUS ACIDOCALDARIUS PROTEIN WITH BETA-LACTAMASE AND RHODANESE DOMAINS
618, 3tp9B, 0.7247, 3.19, 0.162, 465, 191, CRYSTAL STRUCTURE OF ALICYCLOBACILLUS ACIDOCALDARIUS PROTEIN WITH BETA-LACTAMASE AND RHODANESE DOMAINS
619, 1qh5A, 0.7244, 2.62, 0.168, 260, 185, HUMAN GLYOXALASE II WITH S-(N-HYDROXY-N-BROMOPHENYLCARBAMOYL) GLUTATHIONE
620, 1qh3A, 0.7244, 2.55, 0.168, 260, 184, HUMAN GLYOXALASE II WITH CACODYLATE AND ACETATE IONS PRESENT IN THE ACTIVE SITE
621, 2zziB, 0.7230, 2.81, 0.216, 199, 185, CRYSTAL STRUCTURE OF TTHA1623 IN A DI-IRON-BOUND FORM
622, 1qh5B, 0.7228, 2.63, 0.168, 260, 185, HUMAN GLYOXALASE II WITH S-(N-HYDROXY-N-BROMOPHENYLCARBAMOYL) GLUTATHIONE
623, 1qh3B, 0.7222, 2.63, 0.168, 260, 185, HUMAN GLYOXALASE II WITH CACODYLATE AND ACETATE IONS PRESENT IN THE ACTIVE SITE
624, 2zwrA, 0.7219, 2.90, 0.209, 200, 187, CRYSTAL STRUCTURE OF TTHA1623 FROM THERMUS THERMOPHILUS HB8
625, 2zziA, 0.7214, 2.77, 0.217, 198, 184, CRYSTAL STRUCTURE OF TTHA1623 IN A DI-IRON-BOUND FORM
626, 3adrA, 0.7193, 2.99, 0.149, 251, 188, THE FIRST CRYSTAL STRUCTURE OF AN ARCHAEAL METALLO-BETA-LACTAMASE SUPERFAMILY PROTEIN; ST1585 FROM SULFOLOBUS TOKODAII
627, 3adrB, 0.7169, 3.03, 0.149, 248, 188, THE FIRST CRYSTAL STRUCTURE OF AN ARCHAEAL METALLO-BETA-LACTAMASE SUPERFAMILY PROTEIN; ST1585 FROM SULFOLOBUS TOKODAII
628, 2qedA, 0.7161, 2.71, 0.174, 252, 184, CRYSTAL STRUCTURE OF SALMONELLA THYPHIMURIUM LT2 GLYOXALASE II
629, 2r2dC, 0.7083, 3.13, 0.113, 276, 186, STRUCTURE OF A QUORUM-QUENCHING LACTONASE (AIIB) FROM AGROBACTERIUM TUMEFACIENS
630, 2r2dF, 0.7081, 3.17, 0.113, 276, 186, STRUCTURE OF A QUORUM-QUENCHING LACTONASE (AIIB) FROM AGROBACTERIUM TUMEFACIENS
631, 4j5hA, 0.7078, 3.22, 0.135, 250, 185, CRYSTAL STRUCTURE OF B. THURINGIENSIS AIIA MUTANT F107W WITH N- DECANOYL-L-HOMOSERINE BOUND AT THE ACTIVE SITE
632, 3dhaA, 0.7078, 3.24, 0.135, 254, 185, AN ULTRAL HIGH RESOLUTION STRUCTURE OF N-ACYL HOMOSERINE LACTONE HYDROLASE WITH THE PRODUCT N-HEXANOYL-L-HOMOSERINE BOUND AT AN ALTERNATIVE SITE
633, 2r2dD, 0.7075, 3.17, 0.113, 276, 186, STRUCTURE OF A QUORUM-QUENCHING LACTONASE (AIIB) FROM AGROBACTERIUM TUMEFACIENS
634, 2a7mA, 0.7073, 3.25, 0.135, 250, 185, 1.6 ANGSTROM RESOLUTION STRUCTURE OF THE QUORUM-QUENCHING N-ACYL HOMOSERINE LACTONE HYDROLASE OF BACILLUS THURINGIENSIS
635, 3dhcA, 0.7067, 3.25, 0.135, 250, 185, 1.3 ANGSTROM STRUCTURE OF N-ACYL HOMOSERINE LACTONE HYDROLASE WITH THE PRODUCT N-HEXANOYL-L-HOMOCYSTEINE BOUND TO THE CATALYTIC METAL CENTER
636, 3dhbA, 0.7066, 3.26, 0.135, 250, 185, 1.4 ANGSTROM STRUCTURE OF N-ACYL HOMOSERINE LACTONE HYDROLASE WITH THE PRODUCT N-HEXANOYL-L-HOMOSERINE BOUND AT THE CATALYTIC METAL CENTER
637, 2br6A, 0.7061, 3.14, 0.136, 240, 184, CRYSTAL STRUCTURE OF QUORUM-QUENCHING N-ACYL HOMOSERINE LACTONE LACTONASE
638, 2btnA, 0.7060, 3.14, 0.136, 242, 184, CRYSTAL STRUCTURE AND CATALYTIC MECHANISM OF THE QUORUM- QUENCHING N-ACYL HOMOSERINE LACTONE HYDROLASE
639, 5eh9A, 0.7059, 3.26, 0.135, 253, 185, INDIRECT CONTRIBUTIONS OF MUTATIONS UNDERLIE OPTIMIZATION OF NEW ENZYME FUNCTION
640, 2r2dB, 0.7058, 3.19, 0.113, 276, 186, STRUCTURE OF A QUORUM-QUENCHING LACTONASE (AIIB) FROM AGROBACTERIUM TUMEFACIENS
641, 4j5fA, 0.7054, 3.12, 0.130, 250, 184, CRYSTAL STRUCTURE OF B. THURINGIENSIS AIIA MUTANT F107W
642, 2r2dA, 0.7054, 3.18, 0.113, 276, 186, STRUCTURE OF A QUORUM-QUENCHING LACTONASE (AIIB) FROM AGROBACTERIUM TUMEFACIENS
643, 5ehtA, 0.7053, 3.26, 0.146, 252, 185, INDIRECT CONTRIBUTIONS OF MUTATIONS UNDERLIE OPTIMIZATION OF NEW ENZYME FUNCTION
644, 2r2dE, 0.7050, 3.22, 0.113, 276, 186, STRUCTURE OF A QUORUM-QUENCHING LACTONASE (AIIB) FROM AGROBACTERIUM TUMEFACIENS
645, 3eshC, 0.7009, 3.58, 0.104, 266, 192, CRYSTAL STRUCTURE OF A PROBABLE METAL-DEPENDENT HYDROLASE FROM STAPHYLOCOCCUS AUREUS. NORTHEAST STRUCTURAL GENOMICS TARGET ZR314
646, 3eshB, 0.7000, 3.48, 0.110, 266, 191, CRYSTAL STRUCTURE OF A PROBABLE METAL-DEPENDENT HYDROLASE FROM STAPHYLOCOCCUS AUREUS. NORTHEAST STRUCTURAL GENOMICS TARGET ZR314
647, 3eshA, 0.6987, 3.50, 0.110, 268, 191, CRYSTAL STRUCTURE OF A PROBABLE METAL-DEPENDENT HYDROLASE FROM STAPHYLOCOCCUS AUREUS. NORTHEAST STRUCTURAL GENOMICS TARGET ZR314
648, 4kepA, 0.6976, 3.39, 0.129, 273, 186, CRYSTAL STRUCTURE OF 4-PYRIDOXOLACTONASE WILD-TYPE
649, 4keqA, 0.6961, 3.42, 0.124, 270, 186, CRYSTAL STRUCTURE OF 4-PYRIDOXOLACTONASE 5-PYRIDOXOLACTONE BOUND
650, 3aj3A, 0.6896, 3.49, 0.135, 269, 185, CRYSTAL STRUCTURE OF SELENOMETHIONINE SUBSTITUTED 4-PYRIDOXOLACTONASE FROM MESORHIZOBIUM LOTI
651, 4v0hD, 0.6674, 3.25, 0.161, 223, 180, HUMAN METALLO BETA LACTAMASE  DOMAIN CONTAINING PROTEIN 1 (HMBLAC1)
652, 4v0hB, 0.6672, 3.27, 0.173, 221, 179, HUMAN METALLO BETA LACTAMASE  DOMAIN CONTAINING PROTEIN 1 (HMBLAC1)
653, 4v0hC, 0.6671, 3.26, 0.173, 221, 179, HUMAN METALLO BETA LACTAMASE  DOMAIN CONTAINING PROTEIN 1 (HMBLAC1)
654, 4v0hA, 0.6668, 3.28, 0.173, 220, 179, HUMAN METALLO BETA LACTAMASE  DOMAIN CONTAINING PROTEIN 1 (HMBLAC1)
655, 4le6A, 0.6625, 3.71, 0.141, 257, 184, CRYSTAL STRUCTURE OF THE PHOSPHOTRIESTERASE OPHC2 FROM PSEUDOMONAS PSEUDOALCALIGENES
656, 4le6B, 0.6610, 3.68, 0.142, 255, 183, CRYSTAL STRUCTURE OF THE PHOSPHOTRIESTERASE OPHC2 FROM PSEUDOMONAS PSEUDOALCALIGENES
657, 4le6C, 0.6582, 3.70, 0.137, 254, 183, CRYSTAL STRUCTURE OF THE PHOSPHOTRIESTERASE OPHC2 FROM PSEUDOMONAS PSEUDOALCALIGENES
658, 4le6D, 0.6566, 3.66, 0.133, 251, 181, CRYSTAL STRUCTURE OF THE PHOSPHOTRIESTERASE OPHC2 FROM PSEUDOMONAS PSEUDOALCALIGENES
659, 1ztcA, 0.6561, 3.93, 0.121, 207, 182, CRYSTAL STRUCTURE OF A PUTATIVE METALLO-BETA-LACTAMASE (TM0894) FROM THERMOTOGA MARITIMA AT 2.10 A RESOLUTION
660, 1ztcB, 0.6548, 3.86, 0.127, 207, 181, CRYSTAL STRUCTURE OF A PUTATIVE METALLO-BETA-LACTAMASE (TM0894) FROM THERMOTOGA MARITIMA AT 2.10 A RESOLUTION
661, 1ztcD, 0.6544, 3.87, 0.127, 206, 181, CRYSTAL STRUCTURE OF A PUTATIVE METALLO-BETA-LACTAMASE (TM0894) FROM THERMOTOGA MARITIMA AT 2.10 A RESOLUTION
662, 1ztcC, 0.6519, 3.86, 0.122, 205, 180, CRYSTAL STRUCTURE OF A PUTATIVE METALLO-BETA-LACTAMASE (TM0894) FROM THERMOTOGA MARITIMA AT 2.10 A RESOLUTION
663, 4le6E, 0.6478, 3.77, 0.144, 251, 181, CRYSTAL STRUCTURE OF THE PHOSPHOTRIESTERASE OPHC2 FROM PSEUDOMONAS PSEUDOALCALIGENES
664, 5a0tB, 0.6289, 3.96, 0.145, 451, 179, CATALYSIS AND 5  END SENSING BY RIBONUCLEASE RNASE J OF THE METALLO-BETA-LACTAMASE FAMILY
665, 5a0vB, 0.6287, 3.87, 0.146, 451, 178, CATALYSIS AND 5  END SENSING BY RIBONUCLEASE RNASE J OF THE METALLO-BETA-LACTAMASE FAMILY
666, 5a0tA, 0.6271, 3.81, 0.153, 454, 177, CATALYSIS AND 5  END SENSING BY RIBONUCLEASE RNASE J OF THE METALLO-BETA-LACTAMASE FAMILY
667, 5a0vA, 0.6266, 3.94, 0.140, 454, 178, CATALYSIS AND 5  END SENSING BY RIBONUCLEASE RNASE J OF THE METALLO-BETA-LACTAMASE FAMILY
668, 3af6A, 0.6216, 4.36, 0.155, 637, 187, THE CRYSTAL STRUCTURE OF AN ARCHAEAL CPSF SUBUNIT PH1404 FROM PYROCOCCUS HORIKOSHII COMPLEXED WITH RNA-ANALOG
669, 5ws2B, 0.6209, 3.71, 0.107, 463, 178, CRYSTAL STRUCTURE OF MPY-RNASE J (MUTANT S247A) AN ARCHAEAL RNASE J FROM METHANOLOBUS PSYCHROPHILUS R15 COMPLEX WITH RNA
670, 5ws2A, 0.6209, 3.82, 0.106, 463, 179, CRYSTAL STRUCTURE OF MPY-RNASE J (MUTANT S247A) AN ARCHAEAL RNASE J FROM METHANOLOBUS PSYCHROPHILUS R15 COMPLEX WITH RNA
671, 3py5A, 0.6208, 3.49, 0.135, 270, 170, CRYSTAL STRUCTURE OF A BETA-LACTAMASE-LIKE PROTEIN FROM BRUCELLA MELITENSIS BOUND TO AMP
672, 5haaA, 0.6207, 3.81, 0.106, 447, 179, CRYSTAL STRUCTURE OF MPY-RNASE J AN ARCHAEAL RNASE J FROM METHANOLOBUS PSYCHROPHILUS R15
673, 3py6A, 0.6207, 3.49, 0.135, 270, 170, CRYSTAL STRUCTURE OF A BETA-LACTAMASE-LIKE PROTEIN FROM BRUCELLA MELITENSIS BOUND TO GMP
674, 3qh8A, 0.6203, 3.49, 0.135, 272, 170, CRYSTAL STRUCTURE OF A BETA-LACTAMASE-LIKE PROTEIN BOUND TO AMP FROM BRUCELLA MELITENSIS LONG WAVELENGTH SYNCHROTRON DATA
675, 3md7A, 0.6200, 3.49, 0.135, 270, 170, CRYSTAL STRUCTURE OF A BETA-LACTAMASE-LIKE PROTEIN BOUND TO GMP FROM BRUCELLA MELITENSIS
676, 5haaB, 0.6199, 4.02, 0.099, 460, 181, CRYSTAL STRUCTURE OF MPY-RNASE J AN ARCHAEAL RNASE J FROM METHANOLOBUS PSYCHROPHILUS R15
677, 5habA, 0.6192, 4.03, 0.100, 456, 180, CRYSTAL STRUCTURE OF MPY-RNASE J (MUTANT H84A) AN ARCHAEAL RNASE J FROM METHANOLOBUS PSYCHROPHILUS R15 COMPLEX WITH RNA
678, 2xr1A, 0.6192, 4.27, 0.161, 605, 186, DIMERIC ARCHAEAL CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR WITH N-TERMINAL KH DOMAINS (KH-CPSF) FROM METHANOSARCINA MAZEI
679, 2xr1B, 0.6184, 4.28, 0.167, 611, 186, DIMERIC ARCHAEAL CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR WITH N-TERMINAL KH DOMAINS (KH-CPSF) FROM METHANOSARCINA MAZEI
680, 3af5A, 0.6168, 4.26, 0.141, 638, 185, THE CRYSTAL STRUCTURE OF AN ARCHAEAL CPSF SUBUNIT PH1404 FROM PYROCOCCUS HORIKOSHII
681, 5habB, 0.6161, 3.97, 0.116, 463, 181, CRYSTAL STRUCTURE OF MPY-RNASE J (MUTANT H84A) AN ARCHAEAL RNASE J FROM METHANOLOBUS PSYCHROPHILUS R15 COMPLEX WITH RNA
682, 2ycbB, 0.6153, 4.34, 0.152, 635, 184, STRUCTURE OF THE ARCHAEAL BETA-CASP PROTEIN WITH N-TERMINAL KH DOMAINS FROM METHANOTHERMOBACTER THERMAUTOTROPHICUS
683, 4xwwA, 0.6134, 3.87, 0.131, 545, 175, CRYSTAL STRUCTURE OF RNASE J COMPLEXED WITH RNA
684, 4xwtA, 0.6112, 3.83, 0.125, 543, 176, CRYSTAL STRUCTURE OF RNASE J COMPLEXED WITH UMP
685, 4xwtB, 0.6108, 3.87, 0.125, 543, 176, CRYSTAL STRUCTURE OF RNASE J COMPLEXED WITH UMP
686, 3t3nA, 0.6108, 4.09, 0.145, 550, 179, MOLECULAR BASIS FOR THE RECOGNITION AND CLEAVAGE OF RNA (UUCCGU) BY THE BIFUNCTIONAL 5 -3  EXO/ENDORIBONUCLEASE RNASE J
687, 3t3oA, 0.6103, 4.08, 0.156, 553, 179, MOLECULAR BASIS FOR THE RECOGNITION AND CLEAVAGE OF RNA (CUGG) BY THE BIFUNCTIONAL 5 -3  EXO/ENDORIBONUCLEASE RNASE J
688, 4xwwB, 0.6101, 3.95, 0.124, 543, 177, CRYSTAL STRUCTURE OF RNASE J COMPLEXED WITH RNA
689, 3zq4E, 0.6101, 3.84, 0.131, 544, 175, UNUSUAL DUAL ENDO- AND EXO-NUCLEASE ACTIVITY IN THE DEGRADOSOME EXPLAINED BY CRYSTAL STRUCTURE ANALYSIS OF RNASE J1
690, 3zq4C, 0.6101, 3.84, 0.131, 542, 175, UNUSUAL DUAL ENDO- AND EXO-NUCLEASE ACTIVITY IN THE DEGRADOSOME EXPLAINED BY CRYSTAL STRUCTURE ANALYSIS OF RNASE J1
691, 3zq4D, 0.6098, 3.85, 0.126, 538, 175, UNUSUAL DUAL ENDO- AND EXO-NUCLEASE ACTIVITY IN THE DEGRADOSOME EXPLAINED BY CRYSTAL STRUCTURE ANALYSIS OF RNASE J1
692, 3zq4A, 0.6098, 3.85, 0.126, 550, 175, UNUSUAL DUAL ENDO- AND EXO-NUCLEASE ACTIVITY IN THE DEGRADOSOME EXPLAINED BY CRYSTAL STRUCTURE ANALYSIS OF RNASE J1
693, 2ycbA, 0.6098, 4.52, 0.161, 634, 186, STRUCTURE OF THE ARCHAEAL BETA-CASP PROTEIN WITH N-TERMINAL KH DOMAINS FROM METHANOTHERMOBACTER THERMAUTOTROPHICUS
694, 2p4zB, 0.6085, 4.08, 0.131, 276, 175, A FERREDOXIN-LIKE METALLO-BETA-LACTAMASE SUPERFAMILY PROTEIN FROM THERMOANAEROBACTER TENGCONGENSIS
695, 2p4zA, 0.6079, 4.13, 0.136, 275, 176, A FERREDOXIN-LIKE METALLO-BETA-LACTAMASE SUPERFAMILY PROTEIN FROM THERMOANAEROBACTER TENGCONGENSIS
696, 3a4yB, 0.6033, 3.81, 0.118, 431, 169, CRYSTAL STRUCTURE OF H61A MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8
697, 3bk2A, 0.6026, 3.98, 0.144, 535, 174, CRYSTAL STRUCTURE ANALYSIS OF THE RNASE J/UMP COMPLEX
698, 3ielD, 0.6021, 3.79, 0.130, 431, 169, CRYSTAL STRUCTURE OF TTHA0252 FROM THERMUS THERMOPHILUS HB8 COMPLEXED WITH UMP
699, 3idzB, 0.6019, 3.83, 0.124, 431, 169, CRYSTAL STRUCTURE OF S378Q MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8
700, 3ie2D, 0.6016, 3.79, 0.124, 431, 169, CRYSTAL STRUCTURE OF H400V MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8
701, 3ie2B, 0.6015, 3.83, 0.124, 431, 169, CRYSTAL STRUCTURE OF H400V MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8
702, 3bk1A, 0.6015, 3.98, 0.144, 537, 174, CRYSTAL STRUCTURE ANALYSIS OF RNASE J
703, 3iemD, 0.6013, 3.83, 0.130, 431, 169, CRYSTAL STRUCTURE OF TTHA0252 FROM THERMUS THERMOPHILUS HB8 COMPLEXED WITH RNA ANALOG
704, 3ie2A, 0.6013, 3.82, 0.130, 431, 169, CRYSTAL STRUCTURE OF H400V MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8
705, 3ie0D, 0.6012, 3.83, 0.130, 431, 169, CRYSTAL STRUCTURE OF S378Y MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8
706, 3ie0C, 0.6011, 3.85, 0.142, 431, 169, CRYSTAL STRUCTURE OF S378Y MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8
707, 3ie0B, 0.6011, 3.84, 0.130, 431, 169, CRYSTAL STRUCTURE OF S378Y MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8
708, 3idzC, 0.6011, 3.85, 0.142, 431, 169, CRYSTAL STRUCTURE OF S378Q MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8
709, 3idzA, 0.6011, 3.79, 0.130, 431, 169, CRYSTAL STRUCTURE OF S378Q MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8
710, 3iekD, 0.6008, 3.85, 0.136, 431, 169, CRYSTAL STRUCTURE OF NATIVE TTHA0252 FROM THERMUS THERMOPHILUS HB8
711, 3ie0A, 0.6006, 3.80, 0.124, 431, 169, CRYSTAL STRUCTURE OF S378Y MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8
712, 3ie2C, 0.6005, 3.84, 0.130, 431, 169, CRYSTAL STRUCTURE OF H400V MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8
713, 3iemB, 0.6004, 3.83, 0.130, 431, 169, CRYSTAL STRUCTURE OF TTHA0252 FROM THERMUS THERMOPHILUS HB8 COMPLEXED WITH RNA ANALOG
714, 3ie1B, 0.6004, 3.77, 0.119, 431, 168, CRYSTAL STRUCTURE OF H380A MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8 COMPLEXED WITH RNA
715, 3idzD, 0.6004, 3.85, 0.136, 431, 169, CRYSTAL STRUCTURE OF S378Q MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8
716, 3a4yA, 0.6004, 3.80, 0.124, 431, 169, CRYSTAL STRUCTURE OF H61A MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8
717, 2i7tA, 0.6004, 4.53, 0.098, 404, 183, STRUCTURE OF HUMAN CPSF-73
718, 3a4yD, 0.6003, 3.85, 0.124, 431, 169, CRYSTAL STRUCTURE OF H61A MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8
719, 3ielC, 0.6001, 3.81, 0.130, 431, 169, CRYSTAL STRUCTURE OF TTHA0252 FROM THERMUS THERMOPHILUS HB8 COMPLEXED WITH UMP
720, 3iekC, 0.6001, 3.81, 0.124, 431, 169, CRYSTAL STRUCTURE OF NATIVE TTHA0252 FROM THERMUS THERMOPHILUS HB8
721, 3a4yC, 0.5999, 3.85, 0.130, 431, 169, CRYSTAL STRUCTURE OF H61A MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8
722, 3iemC, 0.5998, 3.83, 0.136, 431, 169, CRYSTAL STRUCTURE OF TTHA0252 FROM THERMUS THERMOPHILUS HB8 COMPLEXED WITH RNA ANALOG
723, 3ie1D, 0.5992, 3.81, 0.130, 431, 169, CRYSTAL STRUCTURE OF H380A MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8 COMPLEXED WITH RNA
724, 3ie1C, 0.5991, 3.79, 0.125, 431, 168, CRYSTAL STRUCTURE OF H380A MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8 COMPLEXED WITH RNA
725, 3ielB, 0.5990, 3.81, 0.136, 431, 169, CRYSTAL STRUCTURE OF TTHA0252 FROM THERMUS THERMOPHILUS HB8 COMPLEXED WITH UMP
726, 3iemA, 0.5989, 3.82, 0.130, 431, 169, CRYSTAL STRUCTURE OF TTHA0252 FROM THERMUS THERMOPHILUS HB8 COMPLEXED WITH RNA ANALOG
727, 3iekB, 0.5987, 3.74, 0.131, 431, 168, CRYSTAL STRUCTURE OF NATIVE TTHA0252 FROM THERMUS THERMOPHILUS HB8
728, 3ielA, 0.5986, 3.74, 0.131, 431, 168, CRYSTAL STRUCTURE OF TTHA0252 FROM THERMUS THERMOPHILUS HB8 COMPLEXED WITH UMP
729, 2i7vA, 0.5976, 4.36, 0.121, 433, 182, STRUCTURE OF HUMAN CPSF-73
730, 3iekA, 0.5956, 3.83, 0.131, 431, 168, CRYSTAL STRUCTURE OF NATIVE TTHA0252 FROM THERMUS THERMOPHILUS HB8
731, 3ie1A, 0.5943, 3.82, 0.131, 431, 168, CRYSTAL STRUCTURE OF H380A MUTANT TTHA0252 FROM THERMUS THERMOPHILUS HB8 COMPLEXED WITH RNA
732, 2dkfB, 0.5933, 3.90, 0.131, 424, 168, CRYSTAL STRUCTURE OF TTHA0252 FROM THERMUS THERMOPHILUS HB8 A RNA DEGRADATION PROTEIN OF THE METALLO-BETA-LACTAMASE SUPERFAMILY
733, 2dkfA, 0.5909, 3.93, 0.125, 424, 168, CRYSTAL STRUCTURE OF TTHA0252 FROM THERMUS THERMOPHILUS HB8 A RNA DEGRADATION PROTEIN OF THE METALLO-BETA-LACTAMASE SUPERFAMILY
734, 2dkfC, 0.5905, 3.82, 0.126, 424, 167, CRYSTAL STRUCTURE OF TTHA0252 FROM THERMUS THERMOPHILUS HB8 A RNA DEGRADATION PROTEIN OF THE METALLO-BETA-LACTAMASE SUPERFAMILY
735, 2dkfD, 0.5899, 3.77, 0.127, 424, 166, CRYSTAL STRUCTURE OF TTHA0252 FROM THERMUS THERMOPHILUS HB8 A RNA DEGRADATION PROTEIN OF THE METALLO-BETA-LACTAMASE SUPERFAMILY
736, 1zkpA, 0.5881, 3.69, 0.098, 246, 163, 1.5A RESOLUTION CRYSTAL STRUCTURE OF A METALLO BETA LACTAMASE FAMILY PROTEIN THE ELAC HOMOLGUE OF BACILLUS ANTHRACIS A PUTATIVE RIBONUCLEASE
737, 1zkpB, 0.5869, 3.60, 0.099, 246, 162, 1.5A RESOLUTION CRYSTAL STRUCTURE OF A METALLO BETA LACTAMASE FAMILY PROTEIN THE ELAC HOMOLGUE OF BACILLUS ANTHRACIS A PUTATIVE RIBONUCLEASE
738, 1zkpD, 0.5865, 3.61, 0.099, 246, 162, 1.5A RESOLUTION CRYSTAL STRUCTURE OF A METALLO BETA LACTAMASE FAMILY PROTEIN THE ELAC HOMOLGUE OF BACILLUS ANTHRACIS A PUTATIVE RIBONUCLEASE
739, 1zkpC, 0.5865, 3.66, 0.099, 240, 162, 1.5A RESOLUTION CRYSTAL STRUCTURE OF A METALLO BETA LACTAMASE FAMILY PROTEIN THE ELAC HOMOLGUE OF BACILLUS ANTHRACIS A PUTATIVE RIBONUCLEASE
740, 3h3eA, 0.5815, 3.79, 0.117, 252, 162, CRYSTAL STRUCTURE OF TM1679 A METAL-DEPENDENT HYDROLASE OF THE BETA-LACTAMASE SUPERFAMILY
741, 3zwfB, 0.5809, 4.10, 0.095, 259, 169, CRYSTAL STRUCTURE OF HUMAN TRNASE Z SHORT FORM (ELAC1).
742, 3zwfA, 0.5802, 4.12, 0.095, 259, 169, CRYSTAL STRUCTURE OF HUMAN TRNASE Z SHORT FORM (ELAC1).
743, 3bv6C, 0.5778, 4.03, 0.108, 353, 166, CRYSTAL STRUCTURE OF UNCHARACTERIZED METALLO PROTEIN FROM VIBRIO CHOLERAE WITH BETA-LACTAMASE LIKE FOLD
744, 3bv6B, 0.5776, 4.03, 0.108, 354, 166, CRYSTAL STRUCTURE OF UNCHARACTERIZED METALLO PROTEIN FROM VIBRIO CHOLERAE WITH BETA-LACTAMASE LIKE FOLD
745, 3bv6F, 0.5770, 4.04, 0.108, 354, 166, CRYSTAL STRUCTURE OF UNCHARACTERIZED METALLO PROTEIN FROM VIBRIO CHOLERAE WITH BETA-LACTAMASE LIKE FOLD
746, 3bv6A, 0.5770, 4.04, 0.108, 353, 166, CRYSTAL STRUCTURE OF UNCHARACTERIZED METALLO PROTEIN FROM VIBRIO CHOLERAE WITH BETA-LACTAMASE LIKE FOLD
747, 3bv6E, 0.5765, 4.05, 0.108, 354, 166, CRYSTAL STRUCTURE OF UNCHARACTERIZED METALLO PROTEIN FROM VIBRIO CHOLERAE WITH BETA-LACTAMASE LIKE FOLD
748, 3bv6D, 0.5762, 4.05, 0.108, 354, 166, CRYSTAL STRUCTURE OF UNCHARACTERIZED METALLO PROTEIN FROM VIBRIO CHOLERAE WITH BETA-LACTAMASE LIKE FOLD
749, 2wymA, 0.5730, 4.34, 0.087, 303, 172, STRUCTURE OF A METALLO-B-LACTAMASE
750, 2wymE, 0.5727, 4.24, 0.094, 300, 170, STRUCTURE OF A METALLO-B-LACTAMASE
751, 2wymF, 0.5724, 4.18, 0.090, 300, 167, STRUCTURE OF A METALLO-B-LACTAMASE
752, 2wymD, 0.5684, 4.22, 0.096, 300, 166, STRUCTURE OF A METALLO-B-LACTAMASE
753, 2wymB, 0.5684, 4.19, 0.096, 300, 167, STRUCTURE OF A METALLO-B-LACTAMASE
754, 2wymC, 0.5670, 4.31, 0.108, 297, 167, STRUCTURE OF A METALLO-B-LACTAMASE
755, 2wylA, 0.5599, 4.32, 0.088, 296, 170, APO STRUCTURE OF A METALLO-B-LACTAMASE
756, 2wylF, 0.5590, 4.36, 0.088, 294, 171, APO STRUCTURE OF A METALLO-B-LACTAMASE
757, 2wylE, 0.5584, 4.37, 0.094, 294, 171, APO STRUCTURE OF A METALLO-B-LACTAMASE
758, 3x2yA, 0.5571, 4.02, 0.139, 227, 158, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE H8A FROM THERMOTOGA MARITIMA
759, 2wylB, 0.5569, 4.38, 0.088, 294, 171, APO STRUCTURE OF A METALLO-B-LACTAMASE
760, 2wylC, 0.5567, 4.34, 0.100, 291, 170, APO STRUCTURE OF A METALLO-B-LACTAMASE
761, 3x2zA, 0.5559, 3.85, 0.140, 227, 157, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IN COMPLEX WITH NICKEL FROM THERMOTOGA MARITIMA
762, 3x2zC, 0.5557, 3.79, 0.141, 227, 156, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IN COMPLEX WITH NICKEL FROM THERMOTOGA MARITIMA
763, 3x2yC, 0.5557, 3.85, 0.140, 227, 157, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE H8A FROM THERMOTOGA MARITIMA
764, 3x2zB, 0.5549, 3.87, 0.140, 227, 157, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IN COMPLEX WITH NICKEL FROM THERMOTOGA MARITIMA
765, 3x2yB, 0.5547, 3.86, 0.140, 227, 157, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE H8A FROM THERMOTOGA MARITIMA
766, 3x2xA, 0.5542, 3.81, 0.135, 227, 156, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE H48A FROM THERMOTOGA MARITIMA
767, 3x2xC, 0.5540, 3.81, 0.135, 227, 156, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE H48A FROM THERMOTOGA MARITIMA
768, 3x2xB, 0.5539, 3.83, 0.135, 227, 156, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE H48A FROM THERMOTOGA MARITIMA
769, 2wylD, 0.5509, 4.19, 0.090, 292, 166, APO STRUCTURE OF A METALLO-B-LACTAMASE
770, 3x30A, 0.5448, 3.79, 0.138, 219, 152, CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE FROM THERMOTOGA MARITIMA
771, 4b87A, 0.5264, 4.40, 0.167, 335, 162, CRYSTAL STRUCTURE OF HUMAN DNA CROSS-LINK REPAIR 1A
772, 5nzxA, 0.5238, 4.38, 0.162, 336, 160, CRYSTAL STRUCTURE OF DNA CROSS-LINK REPAIR PROTEIN 1A IN COMPLEX WITH CEFTRIAXONE (ALTERNATIVE SITE)
773, 5nzyA, 0.5223, 4.35, 0.135, 341, 156, CRYSTAL STRUCTURE OF DNA CROSS-LINK REPAIR PROTEIN 1A IN COMPLEX WITH CEFOTAXIME
774, 5q2eA, 0.5211, 4.35, 0.172, 341, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 6) 
775, 5q8qA, 0.5210, 4.40, 0.171, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 236) 
776, 5q7xA, 0.5210, 4.40, 0.171, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 206) 
777, 5q2hA, 0.5209, 4.35, 0.172, 341, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 9) 
778, 5q24A, 0.5209, 4.44, 0.165, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000676A 
779, 5q7sA, 0.5208, 4.37, 0.172, 341, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 201) 
780, 5q6jA, 0.5208, 4.44, 0.165, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 156) 
781, 5ahrA, 0.5208, 4.37, 0.164, 330, 159, CRYSTAL STRUCTURE OF HUMAN DNA CROSS-LINK REPAIR 1A CRYSTAL FORM B
782, 5q40A, 0.5207, 4.46, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 64) 
783, 5q2kA, 0.5207, 4.37, 0.172, 341, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 12) 
784, 5q9vA, 0.5206, 4.43, 0.177, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 277) 
785, 5q25A, 0.5205, 4.43, 0.171, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000532A 
786, 5q8rA, 0.5204, 4.42, 0.177, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 237) 
787, 5q5gA, 0.5204, 4.40, 0.135, 341, 156, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 117) 
788, 5qa2A, 0.5203, 4.43, 0.177, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 284) 
789, 5q6iA, 0.5203, 4.43, 0.171, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 155) 
790, 5q6bA, 0.5203, 4.49, 0.157, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 148) 
791, 5q5oA, 0.5203, 4.45, 0.171, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 125) 
792, 5q26A, 0.5203, 3.61, 0.160, 335, 144, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000710A 
793, 5q9hA, 0.5202, 4.44, 0.170, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 263) 
794, 5q8nA, 0.5202, 4.43, 0.177, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 233) 
795, 5q6xA, 0.5202, 4.40, 0.152, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 170) 
796, 5q6aA, 0.5202, 4.43, 0.171, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 147) 
797, 5q5vA, 0.5202, 4.43, 0.171, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 132) 
798, 5q4wA, 0.5202, 4.36, 0.153, 341, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 97) 
799, 5q46A, 0.5202, 4.40, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 71) 
800, 5q3zA, 0.5202, 4.46, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 63) 
801, 5q29A, 0.5202, 3.63, 0.160, 336, 144, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000058A 
802, 5q1tA, 0.5202, 4.41, 0.152, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000492A 
803, 5q98A, 0.5201, 4.43, 0.171, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 254) 
804, 5q6vA, 0.5201, 4.44, 0.171, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 168) 
805, 5q6hA, 0.5201, 4.43, 0.177, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 154) 
806, 5q6gA, 0.5201, 4.39, 0.165, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 153) 
807, 5q6fA, 0.5201, 4.44, 0.171, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 152) 
808, 5q6eA, 0.5201, 4.43, 0.171, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 151) 
809, 5q4cA, 0.5201, 4.47, 0.170, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 77) 
810, 5q9pA, 0.5200, 4.39, 0.165, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 271) 
811, 5q99A, 0.5200, 4.39, 0.165, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 255) 
812, 5q8wA, 0.5200, 4.44, 0.171, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 242) 
813, 5q86A, 0.5200, 3.64, 0.160, 341, 144, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 215) 
814, 5q5iA, 0.5200, 4.39, 0.165, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 119) 
815, 5q54A, 0.5200, 4.43, 0.177, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 105) 
816, 5q4oA, 0.5200, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 89) 
817, 5q9wA, 0.5199, 4.41, 0.152, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 278) 
818, 5q9aA, 0.5199, 4.39, 0.165, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 256) 
819, 5q8eA, 0.5199, 4.41, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 223) 
820, 5q6sA, 0.5199, 4.43, 0.171, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 165) 
821, 5q6cA, 0.5199, 4.41, 0.152, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 149) 
822, 5q1zA, 0.5199, 3.64, 0.160, 336, 144, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000150A 
823, 5q2mA, 0.5198, 3.65, 0.160, 341, 144, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 14) 
824, 5q95A, 0.5197, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 251) 
825, 5q7zA, 0.5197, 4.47, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 208) 
826, 5q1qA, 0.5197, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000294A 
827, 5q1oA, 0.5197, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000478A 
828, 5q6wA, 0.5196, 4.42, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 169) 
829, 5q6oA, 0.5196, 4.42, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 161) 
830, 5q69A, 0.5196, 4.42, 0.152, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 146) 
831, 5q5fA, 0.5196, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 116) 
832, 5q56A, 0.5196, 4.48, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 107) 
833, 5q3bA, 0.5196, 4.45, 0.171, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 39) 
834, 5q8zA, 0.5195, 4.48, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 245) 
835, 5q88A, 0.5195, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 217) 
836, 5q79A, 0.5195, 4.48, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 182) 
837, 5q73A, 0.5195, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 176) 
838, 5q6lA, 0.5195, 4.42, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 158) 
839, 5q6kA, 0.5195, 4.41, 0.165, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 157) 
840, 5q64A, 0.5195, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 141) 
841, 5q5kA, 0.5195, 4.48, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 121) 
842, 5q57A, 0.5195, 4.44, 0.171, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 108) 
843, 5q43A, 0.5195, 4.36, 0.159, 341, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 67) 
844, 5q3xA, 0.5195, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 61) 
845, 5q3pA, 0.5195, 4.47, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 53) 
846, 5q9nA, 0.5194, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 269) 
847, 5q9dA, 0.5194, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 259) 
848, 5q94A, 0.5194, 4.48, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 250) 
849, 5q8aA, 0.5194, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 219) 
850, 5q7uA, 0.5194, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 203) 
851, 5q7bA, 0.5194, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 184) 
852, 5q6nA, 0.5194, 4.41, 0.165, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 160) 
853, 5q68A, 0.5194, 4.38, 0.159, 341, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 145) 
854, 5q67A, 0.5194, 4.42, 0.152, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 144) 
855, 5q5nA, 0.5194, 4.41, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 124) 
856, 5q4lA, 0.5194, 4.46, 0.170, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 86) 
857, 5q3hA, 0.5194, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 45) 
858, 5q30A, 0.5194, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 28) 
859, 5q84A, 0.5193, 4.48, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 213) 
860, 5q7oA, 0.5193, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 197) 
861, 5q62A, 0.5193, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 139) 
862, 5q5mA, 0.5193, 4.22, 0.136, 341, 154, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 123) 
863, 5q9zA, 0.5192, 4.44, 0.171, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 281) 
864, 5q9oA, 0.5192, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 270) 
865, 5q8iA, 0.5192, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 228) 
866, 5q8hA, 0.5192, 4.42, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 227) 
867, 5q7mA, 0.5192, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 195) 
868, 5q70A, 0.5192, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 173) 
869, 5q66A, 0.5192, 4.44, 0.177, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 143) 
870, 5q59A, 0.5192, 4.41, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 110) 
871, 5q4sA, 0.5192, 4.46, 0.176, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 93) 
872, 5q38A, 0.5192, 4.48, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 36) 
873, 5qa0A, 0.5191, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 282) 
874, 5q9iA, 0.5191, 4.48, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 264) 
875, 5q8lA, 0.5191, 4.42, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 231) 
876, 5q5eA, 0.5191, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 115) 
877, 5q4iA, 0.5191, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 83) 
878, 5q3sA, 0.5191, 4.47, 0.170, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 56) 
879, 5q2tA, 0.5191, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 21) 
880, 5q1xA, 0.5191, 4.18, 0.169, 325, 154, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000085A 
881, 5q1sA, 0.5191, 4.21, 0.155, 335, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH BDOOA011525C 
882, 5q1rA, 0.5191, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000291A 
883, 5qa1A, 0.5190, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 283) 
884, 5q9tA, 0.5190, 4.45, 0.170, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 275) 
885, 5q97A, 0.5190, 4.34, 0.153, 341, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 253) 
886, 5q7yA, 0.5190, 4.39, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 207) 
887, 5q7hA, 0.5190, 4.34, 0.153, 341, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 190) 
888, 5q6zA, 0.5190, 4.42, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 172) 
889, 5q6mA, 0.5190, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 159) 
890, 5q5qA, 0.5190, 4.42, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 127) 
891, 5q4xA, 0.5190, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 98) 
892, 5q4vA, 0.5190, 4.42, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 96) 
893, 5q3iA, 0.5190, 4.48, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 46) 
894, 5q34A, 0.5190, 4.46, 0.170, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 32) 
895, 5q33A, 0.5190, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 31) 
896, 5q2yA, 0.5190, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 26) 
897, 5q2nA, 0.5190, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 15) 
898, 5q9jA, 0.5189, 4.48, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 265) 
899, 5q9bA, 0.5189, 4.39, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 257) 
900, 5q89A, 0.5189, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 218) 
901, 5q83A, 0.5189, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 212) 
902, 5q7jA, 0.5189, 4.18, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 192) 
903, 5q5wA, 0.5189, 4.48, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 133) 
904, 5q58A, 0.5189, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 109) 
905, 5q53A, 0.5189, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 104) 
906, 5q3lA, 0.5189, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 49) 
907, 5q32A, 0.5189, 4.20, 0.155, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 30) 
908, 5q31A, 0.5189, 4.46, 0.170, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 29) 
909, 5q2fA, 0.5189, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 7) 
910, 5q2bA, 0.5189, 4.20, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 3) 
911, 5q2aA, 0.5189, 4.47, 0.170, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 1) 
912, 5q20A, 0.5189, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000524A 
913, 5q9sA, 0.5188, 4.35, 0.153, 341, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 274) 
914, 5q9lA, 0.5188, 4.39, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 267) 
915, 5q9cA, 0.5188, 4.48, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 258) 
916, 5q8pA, 0.5188, 4.42, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 235) 
917, 5q8jA, 0.5188, 4.19, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 229) 
918, 5q81A, 0.5188, 4.48, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 210) 
919, 5q7vA, 0.5188, 4.42, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 204) 
920, 5q7aA, 0.5188, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 183) 
921, 5q76A, 0.5188, 4.42, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 179) 
922, 5q4tA, 0.5188, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 94) 
923, 5q4pA, 0.5188, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 90) 
924, 5q4kA, 0.5188, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 85) 
925, 5q4fA, 0.5188, 4.37, 0.172, 341, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 80) 
926, 5q4dA, 0.5188, 4.19, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 78) 
927, 5q3tA, 0.5188, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 57) 
928, 5q3kA, 0.5188, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 48) 
929, 5q2xA, 0.5188, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 25) 
930, 5q2iA, 0.5188, 4.47, 0.170, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 10) 
931, 5q2dA, 0.5188, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 5) 
932, 5q1wA, 0.5188, 4.50, 0.162, 326, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000546A 
933, 5q9xA, 0.5187, 4.45, 0.170, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 279) 
934, 5q96A, 0.5187, 4.47, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 252) 
935, 5q92A, 0.5187, 4.42, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 248) 
936, 5q8sA, 0.5187, 4.18, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 238) 
937, 5q8dA, 0.5187, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 222) 
938, 5q82A, 0.5187, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 211) 
939, 5q7wA, 0.5187, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 205) 
940, 5q7qA, 0.5187, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 199) 
941, 5q7dA, 0.5187, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 186) 
942, 5q7cA, 0.5187, 4.42, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 185) 
943, 5q6uA, 0.5187, 4.21, 0.155, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 167) 
944, 5q5bA, 0.5187, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 112) 
945, 5q4yA, 0.5187, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 99) 
946, 5q4nA, 0.5187, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 88) 
947, 5q41A, 0.5187, 4.38, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 65) 
948, 5q3wA, 0.5187, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 60) 
949, 5q3jA, 0.5187, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 47) 
950, 5q3gA, 0.5187, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 44) 
951, 5q3cA, 0.5187, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 40) 
952, 5q3aA, 0.5187, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 38) 
953, 5q39A, 0.5187, 4.39, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 37) 
954, 5q2zA, 0.5187, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 27) 
955, 5q2rA, 0.5187, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 19) 
956, 5q2jA, 0.5187, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 11) 
957, 5q2gA, 0.5187, 4.20, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 8) 
958, 5q9yA, 0.5186, 4.39, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 280) 
959, 5q9fA, 0.5186, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 261) 
960, 5q8uA, 0.5186, 4.19, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 240) 
961, 5q8oA, 0.5186, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 234) 
962, 5q8mA, 0.5186, 4.39, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 232) 
963, 5q8kA, 0.5186, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 230) 
964, 5q8fA, 0.5186, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 224) 
965, 5q85A, 0.5186, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 214) 
966, 5q80A, 0.5186, 4.42, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 209) 
967, 5q7pA, 0.5186, 4.20, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 198) 
968, 5q61A, 0.5186, 4.21, 0.155, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 138) 
969, 5q5zA, 0.5186, 4.39, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 136) 
970, 5q5aA, 0.5186, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 111) 
971, 5q4qA, 0.5186, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 91) 
972, 5q3uA, 0.5186, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 58) 
973, 5q3eA, 0.5186, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 42) 
974, 5q35A, 0.5186, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 33) 
975, 5q2oA, 0.5186, 4.52, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 16) 
976, 5q9uA, 0.5185, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 276) 
977, 5q9mA, 0.5185, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 268) 
978, 5q90A, 0.5185, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 246) 
979, 5q8yA, 0.5185, 4.39, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 244) 
980, 5q7fA, 0.5185, 4.21, 0.155, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 188) 
981, 5q7eA, 0.5185, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 187) 
982, 5q78A, 0.5185, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 181) 
983, 5q75A, 0.5185, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 178) 
984, 5q72A, 0.5185, 4.35, 0.153, 341, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 175) 
985, 5q6tA, 0.5185, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 166) 
986, 5q6rA, 0.5185, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 164) 
987, 5q65A, 0.5185, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 142) 
988, 5q5pA, 0.5185, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 126) 
989, 5q5hA, 0.5185, 4.42, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 118) 
990, 5q49A, 0.5185, 4.20, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 74) 
991, 5q45A, 0.5185, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 70) 
992, 5q3yA, 0.5185, 4.19, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 62) 
993, 5q3vA, 0.5185, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 59) 
994, 5q36A, 0.5185, 4.19, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 34) 
995, 5q2vA, 0.5185, 4.42, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 23) 
996, 5q2cA, 0.5185, 4.44, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 4) 
997, 5q22A, 0.5185, 4.45, 0.157, 339, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000728A 
998, 5nzwA, 0.5185, 4.18, 0.161, 334, 155, CRYSTAL STRUCTURE OF DNA CROSS-LINK REPAIR PROTEIN 1A IN COMPLEX WITH CEFTRIAXONE
999, 5q8xA, 0.5184, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 243) 
1000, 5q8cA, 0.5184, 4.20, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 221) 
1001, 5q8bA, 0.5184, 4.20, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 220) 
1002, 5q74A, 0.5184, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 177) 
1003, 5q6pA, 0.5184, 4.35, 0.159, 341, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 162) 
1004, 5q5uA, 0.5184, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 131) 
1005, 5q5lA, 0.5184, 4.44, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 122) 
1006, 5q51A, 0.5184, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 102) 
1007, 5q50A, 0.5184, 4.20, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 101) 
1008, 5q4gA, 0.5184, 4.44, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 81) 
1009, 5q4bA, 0.5184, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 76) 
1010, 5q42A, 0.5184, 4.39, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 66) 
1011, 5q3oA, 0.5184, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 52) 
1012, 5q3nA, 0.5184, 4.42, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 51) 
1013, 5q3dA, 0.5184, 4.38, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 41) 
1014, 5q2wA, 0.5184, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 24) 
1015, 5q2pA, 0.5184, 4.44, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 17) 
1016, 5q27A, 0.5184, 4.49, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000421A 
1017, 5q9eA, 0.5183, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 260) 
1018, 5q93A, 0.5183, 4.36, 0.153, 341, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 249) 
1019, 5q7rA, 0.5183, 4.21, 0.155, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 200) 
1020, 5q7iA, 0.5183, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 191) 
1021, 5q7gA, 0.5183, 4.20, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 189) 
1022, 5q60A, 0.5183, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 137) 
1023, 5q4mA, 0.5183, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 87) 
1024, 5q4eA, 0.5183, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 79) 
1025, 5q4aA, 0.5183, 4.44, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 75) 
1026, 5q3rA, 0.5183, 4.21, 0.155, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 55) 
1027, 5q37A, 0.5183, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 35) 
1028, 5q2sA, 0.5183, 4.39, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 20) 
1029, 5q2lA, 0.5183, 4.44, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 13) 
1030, 5q9kA, 0.5182, 4.39, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 266) 
1031, 5q8vA, 0.5182, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 241) 
1032, 5q8tA, 0.5182, 4.20, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 239) 
1033, 5q7lA, 0.5182, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 194) 
1034, 5q6yA, 0.5182, 4.44, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 171) 
1035, 5q5sA, 0.5182, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 129) 
1036, 5q5jA, 0.5182, 4.20, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 120) 
1037, 5q5dA, 0.5182, 4.39, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 114) 
1038, 5q5cA, 0.5182, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 113) 
1039, 5q48A, 0.5182, 4.38, 0.159, 341, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 73) 
1040, 5q3qA, 0.5182, 4.39, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 54) 
1041, 5q3fA, 0.5182, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 43) 
1042, 5q1kA, 0.5182, 4.20, 0.161, 331, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000074A 
1043, 5q71A, 0.5181, 4.20, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 174) 
1044, 5q5yA, 0.5181, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 135) 
1045, 5q5xA, 0.5181, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 134) 
1046, 5q4uA, 0.5181, 4.37, 0.152, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 95) 
1047, 5q4rA, 0.5181, 4.21, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 92) 
1048, 5q3mA, 0.5181, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 50) 
1049, 5q2uA, 0.5181, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 22) 
1050, 5q28A, 0.5181, 4.21, 0.161, 336, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000186A 
1051, 5q91A, 0.5180, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 247) 
1052, 5q7tA, 0.5180, 4.44, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 202) 
1053, 5q7kA, 0.5180, 4.21, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 193) 
1054, 5q55A, 0.5180, 4.40, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 106) 
1055, 5q44A, 0.5180, 4.43, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 69) 
1056, 5q1yA, 0.5180, 4.43, 0.164, 340, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000032A 
1057, 5q9gA, 0.5179, 4.51, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 262) 
1058, 5q6dA, 0.5179, 4.34, 0.166, 341, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 150) 
1059, 5q4zA, 0.5179, 4.40, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 100) 
1060, 5q4jA, 0.5179, 4.40, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 84) 
1061, 5q1pA, 0.5179, 4.21, 0.161, 335, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000299A 
1062, 5q6qA, 0.5178, 4.40, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 163) 
1063, 5q4hA, 0.5178, 4.48, 0.170, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 82) 
1064, 5q47A, 0.5178, 4.44, 0.164, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 72) 
1065, 5q23A, 0.5178, 4.50, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000543A 
1066, 5q1jA, 0.5178, 4.22, 0.155, 335, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMSOA000341B 
1067, 5q9rA, 0.5177, 4.37, 0.159, 341, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 273) 
1068, 5q9qA, 0.5177, 4.40, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 272) 
1069, 5q8gA, 0.5176, 4.42, 0.152, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 225) 
1070, 5q1uA, 0.5176, 4.22, 0.161, 332, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000351A 
1071, 5q1nA, 0.5176, 4.46, 0.151, 341, 159, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000295A 
1072, 5q87A, 0.5175, 4.51, 0.162, 341, 160, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 216) 
1073, 5q2qA, 0.5175, 4.41, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 18) 
1074, 5q63A, 0.5174, 4.22, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 140) 
1075, 5q5rA, 0.5174, 4.22, 0.155, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 128) 
1076, 5q77A, 0.5173, 4.38, 0.165, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 180) 
1077, 5q52A, 0.5173, 4.41, 0.158, 341, 158, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 103) 
1078, 5q7nA, 0.5170, 4.38, 0.159, 341, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 196) 
1079, 5q5tA, 0.5170, 4.22, 0.161, 341, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A AFTER INITIAL REFINEMENT WITH NO LIGAND MODELLED (STRUCTURE 130) 
1080, 5q1lA, 0.5169, 4.35, 0.167, 341, 156, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000073A 
1081, 5q1vA, 0.5168, 4.34, 0.153, 339, 157, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000166A 
1082, 5ahoA, 0.5128, 4.49, 0.157, 314, 159, CRYSTAL STRUCTURE OF HUMAN 5  EXONUCLEASE APOLLO
1083, 5q1mA, 0.5058, 4.49, 0.168, 337, 155, PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF DCLRE1A IN COMPLEX WITH FMOPL000740A 
